{"id":4986,"date":"2021-07-25T18:24:04","date_gmt":"2021-07-25T15:24:04","guid":{"rendered":"https:\/\/neolife.com.tr\/doc-dr-orhan-celen\/"},"modified":"2023-04-26T16:55:20","modified_gmt":"2023-04-26T13:55:20","slug":"doc-dr-orhan-celen","status":"publish","type":"post","link":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/","title":{"rendered":"\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"4986\" class=\"elementor elementor-4986\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-16dc2d2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"16dc2d2\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-ee091c9\" data-id=\"ee091c9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-1fb7d1c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1fb7d1c\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-d26e5e4\" data-id=\"d26e5e4\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5683c13 elementor-widget elementor-widget-image\" data-id=\"5683c13\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"200\" height=\"245\" src=\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/07\/orhan-celen-genel-cerrahi-cerrahi-onkoloji-uzmani-neolife-kanser-merkezi2.jpg\" class=\"attachment-large size-large wp-image-364\" alt=\"\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-82b3620 elementor-widget elementor-widget-heading\" data-id=\"82b3620\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u0421\u043f\u0435\u0446\u0438\u0430\u043b\u0438\u0441\u0442 \u043f\u043e \u043e\u0431\u0449\u0435\u0439 \u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438 \u0438 \u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-9119f28\" data-id=\"9119f28\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-377e7e4 elementor-widget elementor-widget-heading\" data-id=\"377e7e4\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-5e0c33f elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"5e0c33f\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bc05f1a elementor-widget elementor-widget-heading\" data-id=\"bc05f1a\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">E\u011fitim\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-244fb58 elementor-widget elementor-widget-text-editor\" data-id=\"244fb58\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"div_block-73-363\" class=\"ct-div-block doktor-div\"><div id=\"text_block-75-363\" class=\"ct-text-block doktor-text\"><b>2012<\/b><br \/>Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Dr. A.Y.Ankara Onkoloji E\u011fitim ve Ara\u015ft\u0131rma Hastanesi \/ Yan Dal Uzmanl\u0131k \u2013 Cerrahi Onkoloji<br \/><br \/><b>2008<\/b><br \/>Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Dr. A.Y.Ankara Onkoloji E\u011fitim ve Ara\u015ft\u0131rma Hastanesi \/ \u00dcniversite Do\u00e7enti<br \/><br \/><b>1997<\/b><br \/>Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Dr. A.Y.Ankara Onkoloji E\u011fitim ve Ara\u015ft\u0131rma Hastanesi \/ T\u0131pta Uzmanl\u0131k<br \/><br \/><b>1990<\/b><br \/>Ankara \u00dcniversitesi \/ T\u0131p Fak\u00fcltesi<br \/><br \/><b>1984<\/b><br \/>TED \u00d6zel Ankara Koleji<br \/><br \/><b>1981<\/b><br \/>TED \u00d6zel Ankara Koleji<br \/><br \/><b>1977<\/b><br \/>Kurtulu\u015f \u0130lkokulu, Ankara<\/div><\/div><div id=\"div_block-77-363\" class=\"ct-div-block doktor-div\">\u00a0<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ab07726 elementor-widget elementor-widget-heading\" data-id=\"ab07726\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u0130\u015f Deneyimi\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-41494b9 elementor-widget elementor-widget-text-editor\" data-id=\"41494b9\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"div_block-77-363\" class=\"ct-div-block doktor-div\"><div id=\"text_block-79-363\" class=\"ct-text-block doktor-text\"><b>2016 \u2013 Halen<br \/><\/b>Neolife T\u0131p Merkezi<br \/><br \/><b>2015 \u2013 2016<br \/><\/b>Bah\u00e7e\u015fehir \u00dcniversitesi T\u0131p Fak\u00fcltesi, Genel Cerrahi ABD, \u00d6\u011fretim G\u00f6revlisi<br \/><br \/><b>2011 \u2013 2015<br \/><\/b>\u00d6zel Medical Park Gebze Hastanesi, Genel Cerrahi Do\u00e7enti<br \/><br \/><b>2009 \u2013 2011<br \/><\/b>\u00d6zel \u0130stanbul Cerrahi Hastanesi, Genel Cerrahi Do\u00e7enti<br \/><br \/><b>1997 \u2013 2009<br \/><\/b>S.B.Dr.A.Y. Ankara Onkoloji E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Genel Cerrahi Uzman\u0131 ve Do\u00e7enti. (Cerrahi Onkoloji E\u011fitim S\u00fcreci)<br \/><br \/><b>1998 \u2013 2000<br \/><\/b>\u015e\u0131rnak Asker Hastanesi, Tabip Aste\u011fmen ve Te\u011fmen<br \/><br \/><b>1993 \u2013 1995<br \/><\/b>Boston University School of Medicine, The University Hospital, Section of Surgical Oncology, Konuk asistan<br \/><br \/><b>1991 \u2013 1997<br \/><\/b>S.B.Dr.A.Y. Ankara Onkoloji E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Genel Cerrahi Asistan\u0131<\/div><\/div><div id=\"div_block-87-363\" class=\"ct-div-block doktor-div\">\u00a0<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-42ef675 elementor-widget elementor-widget-heading\" data-id=\"42ef675\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Verdi\u011fi E\u011fitimler<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1e4a623 elementor-widget elementor-widget-text-editor\" data-id=\"1e4a623\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"_rich_text-99-366\" class=\"oxy-rich-text \"><div class=\"wpb_text_column wpb_content_element vc_custom_1541608118372\"><div class=\"wpb_wrapper\"><ul><li>T\u00fcrk Jinekoloji ve Obstetrik Derne\u011fi<\/li><li>\u00dcreme Sa\u011fl\u0131\u011f\u0131 ve \u0130nfertilite Derne\u011fi<\/li><\/ul><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-47a20c3 elementor-widget elementor-widget-heading\" data-id=\"47a20c3\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u00dcyelikler<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bad3341 elementor-widget elementor-widget-text-editor\" data-id=\"bad3341\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"div_block-97-363\" class=\"ct-div-block doktor-div\"><div id=\"_rich_text-99-363\" class=\"oxy-rich-text \"><div class=\"wpb_text_column wpb_content_element vc_custom_1541608118372\"><div class=\"wpb_wrapper\"><ul><li>Ulusal Cerrahi Derne\u011fi<\/li><li>Ankara Cerrahi Derne\u011fi,<\/li><li>Ankara Meme Hastal\u0131klar\u0131 Derne\u011fi<\/li><li>Meme Hastal\u0131klar\u0131 Federasyonu<\/li><li>European Society of Surgical Oncology<\/li><\/ul><\/div><\/div><\/div><\/div><div id=\"div_block-101-363\" class=\"ct-div-block doktor-div\">\u00a0<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-585ee22 elementor-widget elementor-widget-heading\" data-id=\"585ee22\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u00d6d\u00fcller<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cf56705 elementor-widget elementor-widget-text-editor\" data-id=\"cf56705\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"div_block-101-363\" class=\"ct-div-block doktor-div\"><div id=\"_rich_text-103-363\" class=\"oxy-rich-text \"><div class=\"wpb_text_column wpb_content_element vc_custom_1541608118372\"><div class=\"wpb_wrapper\"><p><strong>*<\/strong>XIV. Ulusal Kanser Kongresi, J\u00fcri Serbest Bildiri \u00d6d\u00fcl\u00fc<\/p><p><strong>Orhan \u00c7elen<\/strong>, Emin Y\u0131ld\u0131r\u0131m, Kaptan G\u00fclben, U\u011fur Berbero\u011flu. Diferansiye tiroid karsinomlu olgularda prognostik skorlama sistemlerinin de\u011feri.<strong><em>XIV. Ulusal Kanser Kongresi,<\/em><\/strong>\u0130stanbul, 30 Nisan-4 May\u0131s<strong>2001.<\/strong><\/p><p><strong>*<\/strong>Ulusal Cerrahi Kongresi 2006 S\u00f6zl\u00fc Sunu Yar\u0131\u015fmas\u0131 \u00fc\u00e7\u00fcnc\u00fcl\u00fck \u00f6d\u00fcl\u00fc<\/p><p><strong>Orhan \u00c7elen<\/strong>, Emin Y\u0131ld\u0131r\u0131m, U\u011fur Berbero\u011flu. Mide kanserinde lenf nodu tutulum oran\u0131n\u0131n prognostik \u00f6nemi.<strong><em>Ulusal Cerrahi Kongresi<\/em><\/strong>, 24-28 May\u0131s,Antalya,<strong>2006.<\/strong><\/p><\/div><\/div><\/div><\/div><div id=\"div_block-105-363\" class=\"ct-div-block doktor-div\">\u00a0<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-db50d09 elementor-widget elementor-widget-heading\" data-id=\"db50d09\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Eserler<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-87b7532 elementor-widget elementor-widget-text-editor\" data-id=\"87b7532\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Uluslararas\u0131 hakemli dergilerde yay\u0131mlanan makaleler:<\/p>\n<p>A1. F.Buruk, U. Berbero\u011flu, I.Pak, E.Aksaz , O.\u00c7elen. \u201cGastric cancer and Helicobacter pylori infection\u201d, British Journal of Surgery, 80,378-379 (1993).<\/p>\n<p>A2. K.\u00d6zgen, U.Berbero\u011flu, M.Alt\u0131nok, E.\u00d6zdemir , O.\u00c7elen. \u201cReconstruction of full-thickness cheek defects using platysma myocutaneous flaps\u201d, European Journal of Plastic Surgery, 16,208-211 (1993).<\/p>\n<p>A3. O.\u00c7elen, M.J.O\u2019Brien, J.C.Melby, R.M.Beazley. \u201cFactors Influencing Outcome of Surgery for Primary Aldosteronism\u201d, Archives of Surgery, 131,646-650 (1996).<\/p>\n<p>A4. A.\u00d6zl\u00fck, E.Y\u0131ld\u0131r\u0131m, S.Oral, O.\u00c7elen, U.Berbero\u011flu. \u201cCarcinomas of the thyroid and breast associated with Pendred\u2019s Syndrome: Report of a case\u201d, Surgery Today, 28,673-674 (1998).<\/p>\n<p>A5. E.Y\u0131ld\u0131r\u0131m, O.\u00c7elen, U.Berbero\u011flu. \u201cThe Turkish experience with curative gastrectomies for gastric carcinoma: Is D2 dissection worthwhile?\u201d, Journal of the American College of Surgeons, 192,25-37 (2001).<\/p>\n<p>A6. H.Alt\u0131nyollar, U.Berbero\u011flu, O.\u00c7elen. \u201cLymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip\u201d, European Journal of Surgical Oncology, 28,72-74 (2002).<\/p>\n<p>A7. O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, K.G\u00fclben, U.Berbero\u011flu. \u201cPrediction of survival in gastric carcinoma related to lymph node grading by the new American Joint Committee on Cancer\/Union International Contre le Cancer System or the Japanese System\u201d, European Journal of Surgery, Suppl 588,33-39 (2002).<\/p>\n<p>A8. O.\u00c7elen, \u0130.Kahraman, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cCorrelation of vascular endothelial growth factor with clinicopathological variables in colorectal cancer patients\u201d, Neoplasma,51(4), 293-299 (2004).<\/p>\n<p>A9. U.Berbero\u011flu, E.Y\u0131ld\u0131r\u0131m, O.\u00c7elen. \u201cSerum levels of tumor necrosis factor alpha correlate with response to neoadjuvant chemotherapy in locally advanced breast cancer\u201d, The International Journal of Biological Markers 19(2),130-134 (2004).<\/p>\n<p>A10. O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cFactors ,influencing outcome of surgery for stage I rectal cancer\u201d, Neoplasma 51(6), 487-490 (2004).<\/p>\n<p>A11. E. Y\u0131ld\u0131r\u0131m, O. \u00c7elen, K. G\u00fclben and U. Berbero\u011flu. \u201dThe surgical management of incidental gallbladder carcinoma\u201d, European Journal of Surgical Oncology 31(1),45-52 (2005).<\/p>\n<p>A12. O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. Prevention of wound edge necrosis by local application of dimethylsulfoxide. Acta Chirurgica Belgica, 105,287-290 (2005).<\/p>\n<p>A13. O. \u00c7elen, E Y\u0131ld\u0131r\u0131m, N \u00d6zen, C Sonmez. \u201cPredictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast\u201d carcinoma. Neoplasma 53,347-51 (2006).<\/p>\n<p>A14- O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cPrognost\u0131c impact of positive lymph node ratio in gastric carcinoma\u201d, Journal of Surgical oncology ;96(2):95-101. (2007).<\/p>\n<p>A15- Kaptan G\u00fclben, U\u011fur Berbero\u011flu, Orhan \u00c7elen, H.Hakan Mersin. Incidental papillary microcarcinoma of the thyroid-factors affecting lymph node metastasis. Langenbecks Archives of Surgery333(1):25-29 (2008).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-666d8c7 elementor-widget elementor-widget-heading\" data-id=\"666d8c7\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Uluslararas\u0131 bilimsel toplant\u0131larda sunulan ve bildiri kitab\u0131nda (Proceedings) bas\u0131lan bildiriler :\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-063aafc elementor-widget elementor-widget-text-editor\" data-id=\"063aafc\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>B1- O.\u00c7elen, U.Berbero\u011flu, E.Ero\u011flu, S.\u00c7aml\u0131bel. \u201cComplications related to port-catheter systems in regional chemotherapy\u201d, VI. International Conference on Regional Cancer Treatment. Wiesbaden, July 12-14,1993.(Poster)<\/p><p>B2- M.Berbero\u011flu, N.Kurt, O.\u00c7elen, E.G\u00fcndo\u011fdu, F.G\u00f6z\u00fcb\u00fcy\u00fck. \u201cA new laparoscopic maneuver resembling the Pringle\u2019s\u201d, 1999 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), San Antonio, Texas, USA, March 24-27,1999.(Poster)<\/p><p>B3- E Y\u0131ld\u0131r\u0131m, U, Berbero\u011flu, O. \u00c7elen, E.Semerci, S.Kalkan. The effect of topical dimethyl sulfoxide on surgical flaps. European Cancer Conference (ECCO 10), Viana, September 12-16 1999. (Poster)<\/p><p>B4- E.Y\u0131ld\u0131r\u0131m, O.\u00c7elen, K.G\u00fclben, U.Berbero\u011flu. Is the AJCC\/UICC Staging system for gastric carcinoma more valid than the Japanese system? Eurosurgery 2000. \u0130stanbul, 20-24 June 2000. (S\u00f6zel)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b66543a elementor-widget elementor-widget-heading\" data-id=\"b66543a\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Ulusal hakemli dergilerde yay\u0131mlanan makaleler :\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ac74543 elementor-widget elementor-widget-text-editor\" data-id=\"ac74543\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>C1. K.Bak\u0131r, O.\u00c7elen, U.Berbero\u011flu, T.G\u00fcrkale, N.Kapucuo\u011flu. \u201cMemenin primer osteosarkomu\u201d, T\u00fcrk Patoloji Dergisi, 10, 40-42 (1994).<\/p><p>C2. H.Alt\u0131nyollar, U.Berbero\u011flu, O.\u00c7elen, A.\u00d6zl\u00fck. \u201cMeme kanserinde kemik metastaz\u0131 ile visseral organ tutulumu aras\u0131ndaki ili\u015fki\u201d, T\u00fcrk Onkoloji Dergisi, 9, 36-37 (1994).<\/p><p>C3. E.Y\u0131ld\u0131r\u0131m, A.\u00d6zl\u00fck, O.\u00c7elen, U.Berbero\u011flu. \u201cGastrointestinal lenfomalar\u201d, Acta Oncologica Turcica, 28, 101-104 (1995).<\/p><p>C4. E.Y\u0131ld\u0131r\u0131m, T.\u00c7elen, O.\u00c7elen, U.Berbero\u011flu. \u201c\u00dcst ekstremitenin malign t\u00fcm\u00f6rlerinin tedavisinde skapulotorasik amputasyon\u201d, Acta Oncologica Turcica, 28, 116-117 (1995).<\/p><p>C5. A.\u00d6zl\u00fck, O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cDuktal Ektazi: 218 olgunun klinikopatolojik de\u011ferlendirilmesi\u201d, Acta Oncologica Turcica, 29, 34-35 (1996).<\/p><p>C6. H.Alt\u0131nyollar, K.G\u00fclben, O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201c\u0130nce barsa\u011f\u0131n malign t\u00fcm\u00f6rleri\u201d, Acta Oncologica Turcica, 30, 36-37 (1997).<\/p><p>C7. E.Y\u0131ld\u0131r\u0131m, O.\u00c7elen, T.Dalg\u0131\u00e7, H.Alt\u0131nyollar, S.\u00c7aml\u0131bel, U.Berbero\u011flu. \u201cPrimer ve metastatik karaci\u011fer t\u00fcm\u00f6rlerinde intraarteriyel kemoterapi\u201d, Ulusal Cerrahi Dergisi, 14, 277-283 (1998).<\/p><p>C8 O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, K.G\u00fclben, H.Alt\u0131nyollar, S.\u00c7aml\u0131bel,U.Berbero\u011flu. \u201cHepatosell\u00fcler karsinomlu 83 olguda tedavi y\u00f6ntemlerinin de\u011ferlendirilmesi\u201d, Acta Oncologica Turcica, 31, 63-65 (1998).<\/p><p>C9. E.Y\u0131ld\u0131r\u0131m, S.Sancaktar, O. Aktepe, O.\u00c7elen, U.Berbero\u011flu. \u201cBacterial translocation after extended liver resection\u201d, Acta Oncologica Turcica, 32, 7-12 (1999).<\/p><p>C10. O.\u00c7elen, H.Alt\u0131nyollar, U.Berbero\u011flu. \u201cBa\u015f boyun malign melanomlar\u0131nda s\u00fcperfisial parotidektomi ve preaurikuler lenf nodu diseksiyonu\u201d, Acta Oncologica Turcica, 32, 7-12, (1999).<\/p><p>C11. M. Do\u011fan, S.O\u011fuz, O.\u00c7elen. \u201cY\u00fcksek enerjili ate\u015fli silahlarla meydana gelen ekstremite yaralanmalar\u0131\u201d, Ulusal Travma Dergisi, 6, 231-33 (2000).<\/p><p>C12. O.\u00c7elen, S.O\u011fuz, M. Do\u011fan. \u201cKar\u0131na Y\u00f6nelik ate\u015fli silah yaralanmalar\u0131: 164 Olgunun retrospektif analizi\u201d, Ulusal Travma Dergisi, 7, 258-61(2001).<\/p><p>C13. O.\u00c7elen, E.Semerci, U.Berbero\u011flu. \u201cPalpe edilemiyen meme lezyonlar\u0131nda tel lokalizasyon e\u015fli\u011finde biyopsi\u201d, Acta Oncologica Turcica, 34, 46-50 (2001).<\/p><p>C14. E.Semerci, O.\u00c7elen, U.Berbero\u011flu. \u201cDeneysel akut pankreatitte kolesistokinin antagonistinin etkileri\u201d, Ulusal Cerrahi Dergisi, 17, 333-38 (2001).<\/p><p>C15. O.\u00c7elen, T.Dalg\u0131\u00e7, U.Berbero\u011flu. \u201cDeneysel peritonit modelinde gran\u00fclosit koloni stim\u00fcle edici fakt\u00f6r\u00fcn t\u00fcm\u00f6r nekrosis fakt\u00f6r alfa ve prognoz \u00fczerine etkisi\u201d, Ulusal Cerrahi Dergisi, 19, 181-187 (2003).<\/p><p>C16. O.\u00c7elen. \u201c Meme ba\u015f\u0131 ak\u0131nt\u0131lar\u0131\u201d, Ankara Cerrahi Dergisi, 7(4),128-134 (2005).<\/p><p>C17. H.Alt\u0131nyollar, U.Berbero\u011flu, K.G\u00fclben, O.\u00c7elen. \u201cMeme kanserinin infraklavikular metastazlar\u0131n\u0131n prognostik parametrelerle ili\u015fkisi\u201d, Gazi T\u0131p Dergisi, 18(1), 18-21 (2007)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c4a3cdb elementor-widget elementor-widget-heading\" data-id=\"c4a3cdb\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Ulusal bilimsel toplant\u0131larda sunulan ve bildiri kitaplar\u0131nda bas\u0131lan bildiriler:\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0cd2d4c elementor-widget elementor-widget-text-editor\" data-id=\"0cd2d4c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>D1. H.Alt\u0131nyollar, U.Berbero\u011flu, O.\u00c7elen, A.\u00d6zl\u00fck. \u201cMeme kanserinde kemik metastaz\u0131 ile visseral organ tutulumu aras\u0131ndaki ili\u015fki\u201d, X. Ulusal Kanser Kongresi, The Marmara, \u0130stanbul,3-7 May\u0131s 1993.(S\u00f6zel)<\/p><p>D2. E.Y\u0131ld\u0131r\u0131m, A.\u00d6zl\u00fck, O.\u00c7elen, U.Berbero\u011flu. \u201cGastrointestinal lenfomalar\u201d, XI. Ulusal Kanser Kongresi, Antalya, Haziran 1995. (Poster)<\/p><p>D3. E.Y\u0131ld\u0131r\u0131m, T.\u00c7elen, O.\u00c7elen, U.Berbero\u011flu. \u201c\u00dcst ekstremitenin malign t\u00fcm\u00f6rlerinin tedavisinde skapulotorasik amputasyon\u201d, XI. Ulusal Kanser Kongresi, Antalya, Haziran 1995. (Poster)<\/p><p>D4. O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, A.\u00d6zl\u00fck, U.Berbero\u011flu. \u201c\u0130nflamatuar meme karsinomu\u201d, 2. Ulusal Meme Hastal\u0131klar\u0131 Kongresi, \u0130stanbul, 19-21 Ekim 1995. (Poster)<\/p><p>D5. A.\u00d6zl\u00fck, O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cDuktal Ektazi: 218 olgunun klinikopatolojik de\u011ferlendirilmesi\u201d, 2. Ulusal Meme Hastal\u0131klar\u0131 Kongresi, \u0130stanbul, 19-21 Ekim 1995. (Poster)<\/p><p>D6. O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cMide kanserinde geni\u015fletilmi\u015f lenfnodu diseksiyonunun yeri\u201d, XII. Ulusal Kanser Kongresi, Belek, Antalya, 23-26 Nisan 1997 (Poster).<\/p><p>D7. O.\u00c7elen, H.Alt\u0131nyollar, U.Berbero\u011flu. \u201cBa\u015f boyun malign melanomlar\u0131nda s\u00fcperfisial parotidektomi ve preaurikuler lenf nodu diseksiyonu\u201d, XII. Ulusal Kanser Kongresi, Belek, Antalya, 23-26 Nisan 1997. (Poster)<\/p><p>D8. E.Y\u0131ld\u0131r\u0131m, O.\u00c7elen, T.Dalg\u0131\u00e7, H.Alt\u0131nyollar, S.\u00c7aml\u0131bel, U.Berbero\u011flu. \u201cPrimer ve metastatik karaci\u011fer t\u00fcm\u00f6rlerinde intraarteriyel kemoterapi\u201d, Hepato-Pankreato-Bilier Bilimler Kongresi, Efes Kongre Merkezi, \u0130zmir. 1-4 Kas\u0131m 1997. (S\u00f6zel)<\/p><p>D9. O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, K.G\u00fclben, H.Alt\u0131nyollar, S.\u00c7aml\u0131bel, U.Berbero\u011flu. \u201cHepatosell\u00fcler karsinomlu 83 olguda tedavi y\u00f6ntemlerinin de\u011ferlendirilmesi\u201d, Hepato-Pankreato-Bilier Bilimler Kongresi, Efes Kongre Merkezi, \u0130zmir. 1-4 Kas\u0131m 1997. (S\u00f6zel)<\/p><p>D10. E.Y\u0131ld\u0131r\u0131m, O.\u00c7elen, U.Berbero\u011flu. \u201cMalign melanomada popliteal disseksiyon\u201d, Ulusal Cerrahi Kongresi\u201998, Efes Kongre Merkezi, \u0130zmir, 6-10 May\u0131s 1998.( Poster)<\/p><p>D11. H.Alt\u0131nyollar, K.G\u00fclben, O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201c\u0130nce barsa\u011f\u0131n malign t\u00fcm\u00f6rleri\u201d, Ulusal Cerrahi Kongresi\u201998, Efes Kongre Merkezi, \u0130zmir, 6-10 May\u0131s 1998. (Poster)<\/p><p>D12. O.\u00c7elen, E.Semerci, B.Ar\u0131ba\u015f, G.Dingil, L.Ku\u015fcu, U.Berbero\u011flu. \u201cPalpe edilemiyen meme lezyonlar\u0131nda tel lokalizasyon e\u015fli\u011finde biyopsi\u201d, Ulusal Cerrahi Kongresi\u201998, Efes Kongre Merkezi, \u0130zmir, 6-10 May\u0131s 1998.(S\u00f6zel)<\/p><p>D13. M.Berbero\u011flu, M.\u00d6zer, O.N.Dilek, M.\u00d6zmen, A.Y\u00fccel, O.\u00c7elen. \u201cLaparoskopik cerrahi temel ve ileri E\u011fitimde 3 y\u0131ll\u0131k kurs ve uygulama sonu\u00e7lar\u0131\u201d, Ulusal Cerrahi Kongresi\u201998, Efes Kongre Merkezi, \u0130zmir, 6-10 May\u0131s 1998.(S\u00f6zel)<\/p><p>D14. M.Berbero\u011flu, M.\u00d6zer, M.\u00d6zmen, O.N.Dilek, O.\u00c7elen. \u201cYo\u011fun preoperative e\u011fitim ile bast\u0131r\u0131lm\u0131\u015f laparoskopik \u00f6\u011frenim e\u011frisi\u201d, Ulusal Cerrahi Kongresi\u201998, Efes Kongre Merkezi, \u0130zmir, 6-10 May\u0131s 1998.(S\u00f6zel)<\/p><p>D15. O.\u00c7elen, S.O\u011fuz, H.\u00d6zberrak, M. Do\u011fan. \u201cKar\u0131na Y\u00f6nelik ate\u015fli silah yaralanmalar\u0131: 164 Olgunun retrospektif analizi\u201d, 3. Ulusal Travma ve Acil Cerrahi Kongresi, Antalya 31 A\u011fustos-04 Eyl\u00fcl 1999. (S\u00f6zel)<\/p><p>D16. M. Do\u011fan, S.O\u011fuz, O.\u00c7elen, H.\u00d6zberrak, \u201cY\u00fcksek enerjili ate\u015fli silahlarla meydana gelen ekstremite yaralanmalar\u0131\u201d, 3. Ulusal Travma ve Acil Cerrahi Kongresi, Antalya 31 A\u011fustos-04 Eyl\u00fcl 1999. (S\u00f6zel)<\/p><p>D17. H.\u00d6zberrak, S.O\u011fuz, O.\u00c7elen, M.Do\u011fan. \u201cUzun namlulu silah ve par\u00e7a tesirli bomba ile meydana gelen damar yaralanmalar\u0131na yakla\u015f\u0131m\u201d, 3. Ulusal Travma ve Acil Cerrahi Kongresi, Antalya 31 A\u011fustos-04 Eyl\u00fcl 1999. (S\u00f6zel)<\/p><p>D18. O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, C.Ayg\u00fcn, U.Berbero\u011flu. \u201cEvre I rektum karsinomunda prognostik fakt\u00f6rler\u201d, I. Ulusal Cerrahi Onkoloji Kongresi, Antalya, 26-28 Ekim 2000. (S\u00f6zel)<\/p><p>D19. E.Y\u0131ld\u0131r\u0131m, O.\u00c7elen, K.G\u00fclben, U.Berbero\u011flu. \u201cMide karsinomunda gen\u00e7 ya\u015f\u0131n prognostik \u00f6nemi\u201d, I. Ulusal Cerrahi Onkoloji Kongresi, Antalya, 26-28 Ekim 2000. (S\u00f6zel)<\/p><p>D20. O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, K.G\u00fclben, U.Berbero\u011flu. \u201cDiferansiye tiroid karsinomlu olgularda prognostik skorlama sistemlerinin de\u011feri\u201d, XIV. Ulusal Kanser Kongresi,2001, \u0130stanbul, 30 Nisan-4 May\u0131s 2001. (S\u00f6zel)<\/p><p>D21. O.\u00c7elen, \u0130.Kahraman, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cMalign melanoma: 28 y\u0131ll\u0131k deneyim\u201d, XIV. Ulusal Kanser Kongresi,2001, \u0130stanbul, 30 Nisan-4 May\u0131s 2001. (Poster)<\/p><p>D22. O.\u00c7elen, S.Kalkan, U.Berbero\u011flu. \u201cMide kanserinde radikal cerrahinin serum interl\u00f6kin 10 d\u00fczeyine etkisi\u201d, Ulusal Cerrahi Kongresi,2002, Kemer, Antalya, 15-19 May\u0131s 2002.(S\u00f6zel).<\/p><p>D23. O.\u00c7elen, U.Berbero\u011flu. \u201cNeoadjuvan kemoterapiye tam aksiller yan\u0131t ve klinik \u00f6nemi\u201d, VII. Ulusal Meme Hastal\u0131klar\u0131 Kongresi, Kemer, Antalya, 16-19 Ekim 2003.(S\u00f6zel).<\/p><p>D24. U.Berbero\u011flu, E.Y\u0131ld\u0131r\u0131m, O.\u00c7elen. \u201cLokal ileri meme kanserinde neoadjuvan kemoterapiye yan\u0131t\u0131n serum TNF-a d\u00fczeyi ile korelasyonu\u201d, VII. Ulusal Meme Hastal\u0131klar\u0131 Kongresi, Kemer, Antalya, 16-19 Ekim 2003.(S\u00f6zel).<\/p><p>D25. O.\u00c7elen, A.Cengiz, U.Berbero\u011flu. \u201cT1 meme kanserli olgularda aksiller lenf nodu pozitifli\u011fine etki eden fakt\u00f6rler\u201d, VIII. Ulusal Meme Hastal\u0131klar\u0131 Kongresi, \u0130stanbul, 21-24 Eyl\u00fcl 2005.(S\u00f6zel).<\/p><p>D26. O. \u00c7elen, E. Y\u0131ld\u0131r\u0131m, U. Berbero\u011flu. Mide kanserinde lenf nodu tutulum oran\u0131n\u0131n prognostik \u00f6nemi . Ulusal Cerrahi Kongresi, 24-28 May\u0131s,Antalya,2006 (S\u00f6zel).<\/p><p>D27. K.G\u00fclben, U. Berbero\u011flu, O. \u00c7elen. \u201cTiroid papiller mikrokarsinomunda lenf nodu metastaz\u0131n\u0131 etkileyen fakt\u00f6rler.\u201d Ulusal Cerrahi Kongresi, 24-28 May\u0131s,Antalya,2006 (S\u00f6zel).<\/p><p>D28. K.G\u00fclben, O. \u00c7elen, U.Berbero\u011flu. Sitolojik olarak kan\u0131tlanm\u0131\u015f aksiller lenf nodu metastaz\u0131nda neoadjuvan kemoterapiye tam yan\u0131t\u0131n prognostik \u00f6nemi. 9. Ulusal MemeHastal\u0131klar\u0131 Kongresi, 5-9 Eyl\u00fcl, Ankara, 2007<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f1aa9a7 elementor-widget elementor-widget-heading\" data-id=\"f1aa9a7\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">At\u0131f yap\u0131lan yay\u0131nlar ve yap\u0131lan at\u0131flar:\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2b1e73a elementor-widget elementor-widget-text-editor\" data-id=\"2b1e73a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"div_block-4-88\" class=\"ct-div-block\"><div id=\"inner_content-228-347\" class=\"ct-inner-content\"><div id=\"div_block-72-363\" class=\"ct-div-block\"><div id=\"div_block-105-363\" class=\"ct-div-block doktor-div\"><div id=\"_rich_text-107-363\" class=\"oxy-rich-text \"><div class=\"wpb_text_column wpb_content_element vc_custom_1541608118372\"><div class=\"wpb_wrapper\"><div id=\"content\" class=\"c-content\"><div class=\"vc_row wpb_row vc_row-fluid\"><div class=\"wpb_column vc_column_container vc_col-sm-12\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"vc_row wpb_row vc_inner vc_row-fluid\"><div class=\"wpb_column vc_column_container vc_col-sm-12\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"wpb_text_column wpb_content_element vc_custom_1558962487411 c-long-text\"><div class=\"wpb_wrapper\"><p><strong>E1-<\/strong>F.Buruk, U. Berbero\u011flu, I.Pak, E.Aksaz ,<strong>O.\u00c7elen<\/strong>. Gastric cancer and Helicobacterpylori infection.<strong>British Journal of Surgery<\/strong>1993;80:378-379.<\/p><ul><li>Lima VP, Silva-Fernandes IJL, Alves MKS, et al. Prevalence of<em>Helicobacter pylori<\/em>genotypes (<em>vac<\/em>A,<em>cag<\/em>A,<em>cag<\/em>E and<em>vir<\/em>B11) in gastric cancer in Brazilian\u2019s patients: An association with histopathological parameters.<strong>Cancer Epidemiology<\/strong>2011; 35: 32-37.<\/li><\/ul><ul><li>VP Lima, MAP Lima, MVP Ferreira, MAP Barros .The relationship between<em>Helicobacter pylori<\/em>genes<em>cag<\/em>E and<em>vir<\/em>B11 and gastric cancer.<strong>J. Infectious Disease<\/strong>2010;14(7):613-617<\/li><\/ul><ul><li>Lima VP, de Lima MAP, Andre AR, e al.H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: Correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World Journal of Gastroenterology 2008;14(6):884-891<\/li><\/ul><ul><li>Rocco A, Nardone G.Diet, H pylori infection and gastric cancer: Evidence and controversies. World Journal of Gastroenterology 2007<strong>;<\/strong>13(21):2901-2912.<\/li><\/ul><ul><li>Hamaguchi K, Ogawa K, Katsube T, Konno S, Aiba M. Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residuel stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residuel stomach before and after Helicobacter pylori eradication.<strong>Langenbecks Archives of Surgery<\/strong>2004;389:83-91.<\/li><\/ul><ul><li>Atalay C, Atalay G, Alt\u0131nok M. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.<strong>Neoplasma<\/strong>2003;50:185-190.<\/li><\/ul><ul><li>Cho HJ, Kim JY, Yoo J, Lee SS. Gastric carcinoma with lymphoid stroma- Incidence of EBV and Helicobacter pylori infection. Applied<strong>Immunohistochemistry &amp; Molecular Morpho<\/strong>2003;11:149-152.<\/li><\/ul><ul><li>Kyrlagkitsis I, Karamanolis DG. Premalignant lesions and conditions for gastric adenocarcinoma: Diagnosis, management and surveillance guidelines.<strong>Hepato-Gastroenterology<\/strong>2003;50:592-600.<\/li><\/ul><ul><li>Katsube T, Ogawa K, Hamaguchi K, Murayama M, Konnno S, Shimakawa T, Naritaka Y, Yagawa H, Kajiwara T, Aiba M. Prevalence of Helicobacter pylori in the residual stomach after gastrectomy for gastric cancer.<strong>Hepato-Gastroenterology<\/strong>2002;49:128-132.<\/li><\/ul><ul><li>Kath R, Fiehler J, Schneider CP, Hoffken K. Gastric cancer in very young adults: apropos four patients and a review of the literature.<strong>Journal of Cancer Research and Clinical Oncology<\/strong>2000;126:233-237.<\/li><\/ul><ul><li>Ashley SW, Evoy D, Daly JM. Stomach In: Schwartz SI, ed.<strong>Principles of Surgery 7<sup>th<\/sup>ed<\/strong>. McGraw Hill; 1999:1181-1215.<\/li><\/ul><ul><li>Jonkers D, Houben P, Hameeteman W, Stobberingh E, de Bruine A, Arends JW, Biemond I, Lundqvist G, Stockbrugger R. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.<strong>Italian Journal of Gastroenterology and Hepatology<\/strong>1999;31:836-841.<\/li><\/ul><ul><li>Tabata H, Fuchigami T, Kobayashi H, Sakai Y, Nakanishi M, Tomioka K, Nakamura S, Fujishima M. Helicobacter pylori and mucosal atrophy in patients with gastric cancer \u2013 A special study regarding the methods for detecting Helicobacter pylori.<strong>Digestive Diseases and Sciences<\/strong>1999;44:2027-2034.<\/li><\/ul><ul><li>Eslick GD, Lim LLY, Byles JE, Xia HHX, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: A meta-analysis.<strong>American Journal of Gastroenterology<\/strong>1999;94:2373-2379.<\/li><\/ul><ul><li>Nyren O. Is Helicobacter pylori really the cause of gastric cancer?<strong>Seminars In Cancer Biology<\/strong>1998;8:275-283.<\/li><\/ul><ul><li>Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian Gerbils.<strong>Gastroenterology<\/strong>1998;115:642-648.<\/li><\/ul><ul><li>Enomoto H, Watanabe H, Nishikura K, Umezawa H, Asakura H. Topographic distribution of Helicobacter pylori in the resected stomach.<strong>European Journal of Gastroenterology &amp; Hepatology<\/strong>1998;10:473-478.<\/li><\/ul><ul><li>Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.<strong>Gastroenterology<\/strong>1998;114:1169-1179.<\/li><\/ul><ul><li>Borch K, Sjostedt C, Hannestad U, Soderholm JD, Franzen L, Mardh S.Asymptomatic Helicobacter pylori gastritis is associated with increased sucrose permeability.<strong>Digestive Diseases and Sciences<\/strong>1998;43:749-753.<\/li><\/ul><ul><li>Iseki K, Tatsuta M, Iishi H, Baba M, Ishiguro S. Helicobacter pylori infection in patients with early gastric cancer by the endoscopic phenol red test.<strong>Gut<\/strong>1998;42:20-23.<\/li><\/ul><ul><li>Wu MS, Yang KC, Shun CT, Hsiao TJ, Lin CC, Wang HP, Chuang SM, Lee WJ, Lin JT. Distinct clinicopathologic characteristics of diffuse- and intestinal-type gastric cancer in Taiwan.<strong>Journal of Clinical Gastroenterology<\/strong>1997;25:646-649.<\/li><\/ul><ul><li>McFarlane GA, Munro A. Helicobacter pylori and gastric cancer.<strong>British Journal of Surgery<\/strong>1997;84:1190-1199.<\/li><\/ul><ul><li>Wu MS, Chen SY, Shun CT, Lee WJ, Wang HP, Wang TH, Chen CJ, Lin JT. Increased prevalence of Helicobacter pylori infection among patients affected with intestinal-type gastric cancer at non-cardiac locations.<strong>Journal of Gastroenterology and Hepatology<\/strong>1997;12:425-428.<\/li><\/ul><ul><li>MartindeArgila C, Boixeda D, Redondo C, Alvarez I, Gisbert JP, Plaza AG, Canton R. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori.<strong>Scandinavian Journal of Gastroenterology<\/strong>1997;32:303-307.<\/li><\/ul><ul><li>Nagahata Y, Kawakita N, Azumi Y, Numata N, Yano M, Saitoh Y. Etiological involvement of Helicobacter pylori in \u201dreflux\u201d gastritis after gastrectomy.<strong>American Journal of Gastroenterology<\/strong>1996;91:2130-2134.<\/li><\/ul><ul><li>McGuigan JE. Helicobacter pylori: The versatile pathogen.<strong>Digestive Diseases<\/strong>1996;14:289-303.<\/li><\/ul><ul><li>Kokkola A, Valle J, Haapiainen R, Sipponen P, Kivilaakso E, Puolakkainen P. Helicobacter pylori infection in young patients with gastric carcinoma.<strong>Scandinavian Journal of Gastroenterology<\/strong>1996;31:643-647.<\/li><\/ul><ul><li>Wu CW, Wu TC, Chang YR, Tsay SH, Yin SJ, Lui WY, Peng FK, Chi CW. Helicobacter pylori infection in patients with gastric adenocarcinoma.<strong>Tumori<\/strong>1996;82:40-44.<\/li><\/ul><ul><li>Hansson LE, Engstrand L, Nyren O, Lindgren A. Prevalence of helicobacter-pylori infection in subtypes of gastric-cancer.<strong>Gastroenterology<\/strong>1995;109:885-888.<\/li><\/ul><ul><li>Hu PJ, Li YY, Zhou MH, Chen MH, Du GG, Huang BJ, Mitchell HM, Hazell SL. Helicobacter-pylori-associated with a high prevalence of duodenal-ulcer disease and a low-prevalence of gastric-cancer in a developing-nation.<strong>Gut<\/strong>1995;36:198-202.<\/li><\/ul><ul><li>Klimpfinger M. Therapeutic relevance of the histological gastritis classification.<strong>Wiener Klinische Wochenschrift<\/strong>1994;106:550-555.<\/li><\/ul><p><strong>E2<\/strong><strong>\u2013<\/strong><strong>O.\u00c7elen<\/strong>, M.J.O\u2019Brien, J.C.Melby, R.M.Beazley. Factors Influencing Outcome of Surgery for Primary Aldosteronism.<strong>Archives of Surgery<\/strong>1996;131:646-650.<\/p><ul><li>Fingeret AL, Lee JA. Adrenal Venous Sampling in Primary Hyperaldosteronism.<strong>Current Surgery Reports<\/strong>2014;2:238.<\/li><\/ul><ul><li>Kim SH, Ahn JE, Hong CE, et al. Changes in the clinical manifestations of primary aldosteronism.<strong>The Korean Journal of Internal Medicine<\/strong>2014;29(2):217-225.<\/li><\/ul><ul><li>Viola A, Tizzani D, Monticone S, et al.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23971697\">Diagnosis and treatment of unilateral forms of primary aldosteronism.<\/a><strong>Curr Hypertens Rev<\/strong>. 2013 May;9(2):156-65.<\/li><\/ul><ul><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=Stowasser%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23402683\">Stowasser M<\/a>,<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=Gordon%20RD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23402683\">Gordon RD<\/a>. The renaissance of primary aldosteronism: what has it taught us?<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=The+renaissance+of+primary+aldosteronism%3A+what+has+it+taught+us%3F\"><strong>Heart Lung Circ.<\/strong><\/a>2013 Jun;22(6):412-20.<\/li><\/ul><ul><li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=Weisbrod%20AB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23090573\">Weisbrod AB<\/a>,<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=Webb%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23090573\">Webb RC<\/a>,<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=Mathur%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23090573\">Mathur A<\/a>, Et al. Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Adrenal+histologic+findings+show+no+difference+in+clinical+presentation+and+outcome+in+primary+hyperaldosteronism\">Ann Surg Oncol.<\/a>2013 Mar;20(3):753-8<\/li><\/ul><ul><li>Uribarrena-Amezaga R, Ortego J, Fuentes J et al. Prognostic value of lymph node micrometastasis in patients with colorectal cancer in Dukes stages A and B (T1-T4, N0, M0).<a href=\"https:\/\/europepmc.org\/search?page=1&amp;query=ISSN:%221130-0108%22\"><strong>Revista Espanola de Enfermedades Digestivas : Organo Oficial de la Sociedad Espanola de Patologia Digestiva<\/strong><\/a>2010, 102(3):176-186.<\/li><\/ul><ul><li>Uribarrena-Amezaga R, Ortego J, Fuentes J et al. Prognostic Value of Microvascular Density in Dukes A and B (T1\u2013T4, N0, M0) Colorectal Carcinoma<strong>.<\/strong><strong>Gastroenterology Research and Practice.<\/strong>2009; Article ID 679830, 7 pages, https:\/\/dx.doi.org\/10.1155\/2009\/679830<\/li><\/ul><ul><li>Mazza A, Armigliato M, Zamboni S, et al.Endocrine arterial hypertension: therapeutic approach in clinical practice. Minerva Endocrinologica 2008;33(4):297-312.<\/li><\/ul><ul><li>Karagiannis A, Tziomalos K, Kakafika AI, et al.Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas<br \/>Endocrine-Related Cancer\u00a0 2008;15(3):693-700.<\/li><\/ul><ul><li>Funder JW, Carey RM, Fardella C, et al.Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology &amp; Metabolism 2008;93(9):3266-3281.<\/li><\/ul><ul><li>Mourad JJ, Girerd X, Milliez P, et al.Urinary aldosterone-to-active-renin ratio: A useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. American Journal of Hypertension 2008;21(7):742-747.<\/li><\/ul><ul><li>Walz MK, Gwosdz R, Levin SL, et al.Retroperitoneoscopic adrenalectomy in Conn\u2019s syndrome caused by adrenal adenomas or nodular hyperplasia. World Journal of Surgery 2008;32(5):847-853.<\/li><\/ul><ul><li>Rossi GP, Bolognesi M, Rizzoni D, et al.Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008;51(5).1366-1371.<\/li><\/ul><ul><li>Zarnegar R, Young WF, Lee J, et al.The aldosteronoma resolution score \u2013 Predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Annals of Surgery 2008;247(3):511-518.<\/li><\/ul><ul><li>Zarnegar R, Lee J, Brunaud L, et al.<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=18&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=8\">Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma<\/a>. Surgery 2007;142(6):921-928.<\/li><\/ul><ul><li>Gordon RD, Stowasser M.Primary aldosteronism: the case for screening<br \/>Nature Clinical Practice Nephrology 2007;3(11):582-583.<\/li><\/ul><ul><li>Lau JHG, Drake W, Matson M.The current role of venous sampling in the localization of endocrine diseaseCardiovascular and Interventional Radiology2007;30(4):555-570.<\/li><\/ul><ul><li>Pang TC, Bambach C, Monaghan JC, et al.Outcomes of laparoscopic adrenalectomy for hyperladosteronismANZ Journal Of Surgery 2007;77(9):768-773.<\/li><\/ul><ul><li>Novello M, Catena C, Nadalini E, et al.Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatmentJournal of Hypertension 2007;25(7):1443-1450.<\/li><\/ul><ul><li>Catena C, Colussi G, Nadahni E, et al.<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=18&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=2&amp;doc=13\">Relationships of plasma renin levels with renal function in patients with primary aldosteronism<\/a>Clinical Journal of The American Society of Nephrology 2007;2(4)722-731.<\/li><\/ul><ul><li>Vesin C, Chabre O, Mallion JM, et al.Diagnosis and post-operative evolution of patients operated for adrenal adenoma (Conn syndrome). A 12-years retrospective study. Archives Des Maladies Du Coeur Et Des Vaisseaux 2007;100(2)121-125.<\/li><li>Young WF.<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=18&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=2&amp;doc=15\">Primary aldosteronism: renaissance of a syndrome<\/a>Clinical Endocrinology 2007;66(5):607-618.<\/li><\/ul><ul><li>Gockel I, Heintz A, Polta M, et al.Long-term results of endoscopic adrenalectomy for Conn\u2019 syndromeAmerican Surgeon 2007;73(2)174-180.<\/li><\/ul><ul><li>Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)Hypertension Research2006;29(Suppl. S):S1-+.<\/li><\/ul><ul><li>Tan YY, Ogilvie JB, Triponez F, et al.<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=18&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=2&amp;doc=18\">Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas<\/a>. World Journal of Surgery 2006;30(5):879-885.<\/li><\/ul><ul><li>Nwariaku FE, Miller BS, Auchus R, et al.<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=18&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=2&amp;doc=19\">Primary hyperaldosteronism \u2013 Effect of adrenal vein sampling on surgical outcome<\/a>. Archives of Surgery 2006;141(5)497-502.<\/li><\/ul><ul><li>Mattsson C, Young WF.<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=18&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=2&amp;doc=20\">Primary aldosteronism: diagnostic and treatment strategies<\/a>. Nature Clinical Practice Nephrology2006;2(4):198-208.<\/li><\/ul><ul><li>Novitsky YW, Kercher KW, Rosen MJ, et al.Clinical outcomes of laparoscopic adrenelectomy for lateralizing nodular hyperplasia.<strong>Surgery<\/strong>2005;138(6):1009-1016.<\/li><\/ul><ul><li>Lumachi F, Ermani M, Basso SMM, et al. Long-term results of adrenelectomy in patients with aldosterone-producing adenomas: Multivariate analysis of factors affecting unresolved hypertension and review of the literature.<strong>American Surgeon<\/strong>2005;71(10):864-869.<\/li><\/ul><ul><li>Ogilvie JB, Duh GY. New approaches to the minimally invasive treatment of adrenal lesions.<strong>Cancer Journal<\/strong>2005;11(1):64-72.<\/li><\/ul><ul><li>Meyer A, Brabant G, Behrend M. Long-term follow-up after adrenelectomy for primary aldosteronism.<strong>World Journal of Surgery<\/strong>2005;29(2):155-159.<\/li><\/ul><ul><li>Stowasser M, Gordon RD. The aldosteron-renin ratioin screening for primary aldosteronism.<strong>Endocrinologist<\/strong>2004;14(5):267-276.<\/li><\/ul><ul><li>Al Fehaily M, Duh GY. Clinical manifestation of aldesteronoma.<strong>Surgical Clinics of North America<\/strong>2004;84(3):887-.<\/li><\/ul><ul><li>Stowasser M, Gordon RD. Primary aldosteronism- careful investigation is essential and rewarding.<strong>Molecular and Cellular Endocrinology<\/strong>2004;217(1-2):33-39.<\/li><\/ul><ul><li>Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF. Extensive personal experience \u2013 increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.<strong>Journal of Clinical Endocrinology and Metabolism<\/strong>2004;89:1045-1050.<\/li><\/ul><ul><li>Stowasser M, Gordon RD. Primary Aldosteronism.<strong>Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism<\/strong>2003;17:591-605.<\/li><\/ul><ul><li>Young WF. Primary aldosteronism- treatment options.<strong>Growth Hormone &amp; IGF Research<\/strong>2003;13(Suppl.A):S102-S108.<\/li><\/ul><ul><li>Stowasser M, Gordon RD. Primary aldosteronism: from genesis to genetics.<strong>Trends in Endocrinology an Metabolism<\/strong>2003;14:310-317.<\/li><\/ul><ul><li>Sidhu S, Gicquel C, Bambach CP, Campbell P, Magarey C, Robinson BG, Delbridge LW. Clinical and molecular aspects of adrenocortical tumourigenesis.<strong>ANZ Journal of Surgery<\/strong>2003;73:727-738.<\/li><\/ul><ul><li>Wheeler MH, Harris DA. Diagnosis and management of primary aldosteronism.<strong>World Journal of Surgery<\/strong>2003;27:627-631.<\/li><\/ul><ul><li>Harris DA, Au-Yong I, Basnyat PS, Sadler GP, Wheeler MH. Review of surgical management of aldosterone secreting tumours of the adrenal cortex.<strong>European Journal of Surgical Oncology<\/strong>2003;29:467-474.<\/li><\/ul><ul><li>Lumachi F, Marzola MC, Zucchetta P, Tregnaghi A, Cecchin D, Favia G, Bui F. Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI.<strong>Nuclear Medicine Communications<\/strong>2003;24:683-688.<\/li><\/ul><ul><li>Young WF. Minireview: Primary aldosteronism \u2013 Changing concepts in diagnosis and treatment.<strong>Endocrinology<\/strong>2003;144:2208-2213.<\/li><\/ul><ul><li>Meria P, Kempf BF, Hermieu JF, Plouin PF,Duclos JM. Laparoscopic management of primary hyperaldosteronism: Clinical experience with 212 cases.<strong>Journal of Urology<\/strong>2003;169(1):32-35.<\/li><\/ul><ul><li>Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism.<strong>British Journal of Surgery<\/strong>2002;89:1587-1593.<\/li><\/ul><ul><li>Fukudome Y, Fujii K, Arima H, Ohya Y, Tsuchihashi T, Abe I, Fujishima M. Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy.<strong>Hypertension Research<\/strong>2002;25:11-18.<\/li><\/ul><ul><li>Rossi H, Kim A, Prinz RA. Primary hyperaldosteronism in the era of laparoscopic adrenalectomy.<strong>American Surgeon<\/strong>2002;68:253-256.<\/li><\/ul><ul><li>Brand M, Dehmel B, Cristow S, Kettritz R. A strange case of hypokalaemia.<strong>Nephrology Dialysis Transplantation<\/strong>2002;17:297-299.<\/li><\/ul><ul><li>Brunt LM, Moley JF, Doherty DM, Lairmore TC, DeBenedetti MK, Quasebarth MA. Outcomes analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tumors.<strong>Surgery<\/strong>2001;130:629-634.<\/li><\/ul><ul><li>Sawka AM, Young WF, Thompson GB, Grant CS, Farley DR, Leibson C, van Heerden JA. Primary aldosteronism: Factors associated with normalization of blood pressure after surgery.<strong>Annals of Internal Medicine<\/strong>2001;135:258-261.<\/li><\/ul><ul><li>Horita Y, Inenaga T, Nakahama H, Ishibashi-Ueda H, Kawano Y, Nakamura S, Horio T, Okuda N, Ando M, Takishita S. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism.<strong>American Journal of Kidney Diseases<\/strong>2001;37:884-889.<\/li><\/ul><ul><li>Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism.<strong>Journal of Hypertension<\/strong>2001;19:353-361.<\/li><\/ul><ul><li>Nocaudie-Calzada M, Huglo D, Lambert M, Ernst O, Proye C, Werneau JL, Marchandise X. Efficacy of iodine-131 6 beta-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism.<strong>European Journal of Nuclear Medicine<\/strong>1999;26:1326-1332.<\/li><\/ul><ul><li>Flood SM, Randolph JF, Gelzer ARM, Refsal K. Primary hyperaldosteronism in two cats.<strong>Journal of the American Animal Hospital Association<\/strong>1999;35:411-146.<\/li><\/ul><ul><li>Winship SM, Winstanley JHR, Hunter JM. Anaesthesia for Conn\u2019s syndrome.<strong>Anaesthesia<\/strong>1999;54:569-574.<\/li><\/ul><ul><li>Shen WT, Lim RC, Siperstein AE, Clark OH, Schecter WP, Hunt TK, Horn JK, Duh QY. Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism.<strong>Archives of Surgery<\/strong>1999;134:628-631.<\/li><\/ul><ul><li>Blumenfeld JD, Vaughan ED. Diagnosis and treatment of primary aldosteronism.<strong>World Journal of Urology<\/strong>1999;17:15-21.<\/li><\/ul><ul><li>Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G. Cardiovascular complications in patients with primary aldosteronism.<strong>American Journal of Kidney Diseases<\/strong>1999;33:261-266.<\/li><\/ul><ul><li>Proye CAG, Mulliez EAR, Carnaille BML, Lecomte-Houcke M, Decoulx M, Wemeau JL, Lefebvre J, Racadot A, Ernst O, Huglo D, Carre A. Essential hypertension: First reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?<strong>Surgery<\/strong>1998;124:1128-1133.<\/li><\/ul><ul><li>Fahmy HI, Melby JC, Mesler DE, Beazley RM, Cho SI, Idelson BA. Primary hyperaldosteronism causing posttransplantation hypertension: Localization by adrenal vein sampling.<strong>American Journal of Kidney Diseases<\/strong>1998;31:853-855.<\/li><\/ul><ul><li>Siren J, Valimaki M, Huikuri K, Sivula A, Voutilainen P, Haapiainen R. Adrenalectomy for primary aldosteronism: Long-term follow-up study in 29 patients.<strong>World Journal of Surgery<\/strong>1998;22:418-422.<\/li><\/ul><ul><li>Young WF. Pheochromocytoma and primary aldosteronism: Diagnostic approaches.<strong>Endocrinology and Metabolism Clinics of North America<\/strong>1997;26:801.<\/li><\/ul><ul><li>Young WF. Primary aldosteronism: Update on diagnosis and treatment.<strong>Endocrinologist<\/strong>1997;7:213-221.<\/li><\/ul><p><strong>E3<\/strong><strong>\u2013<\/strong>E.Y\u0131ld\u0131r\u0131m,<strong>O.\u00c7elen<\/strong>, U.Berbero\u011flu. The Turkish experience with curative gastrectomies for gastric carcinoma: Is D2 dissection worthwhile?<strong>Journal of the American College of Surgeons<\/strong>2001,192:25-37.<\/p><ul><li>TAH El-Fayoumi, HM Fyed, ME Mesiry et al. The applicability of D2 gastrectomy in operable gastric cancer patients: A trial of Alexandria Surgical Oncology Unit<strong>Alexandria J Medicine<\/strong>2013; 49(3):229-234.<\/li><\/ul><ul><li>WH Allum,<a href=\"https:\/\/scholar.google.com.tr\/citations?user=YWZS1fgAAAAJ&amp;hl=en&amp;oi=sra\">JM Blazeby<\/a>, SM Griffin, D Cunningham et al. Guidelines for the management of oesophageal and gastric cancer.<strong>Gut<\/strong>2011;60: 1449-1472.<\/li><\/ul><ul><li>MA Memon, MS Subramanya,<a href=\"https:\/\/scholar.google.com.tr\/citations?user=SSv7euIAAAAJ&amp;hl=en&amp;oi=sra\">S Khan<\/a>et al. Meta-Analysis of D1 Versus D2 Gastrectomy for Gastric Adenocarcinoma<strong>Annals of Surgery<\/strong>2011;253(5):900-911.<\/li><\/ul><ul><li>M Scatizzi, KC Kr\u00f6ning, E Lenzi et al. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a case\u2013control study.<strong>Updates in Surgery<\/strong>2011;63: 17-23.<\/li><\/ul><ul><li>SS Yoon, HK Yang. Lymphadenectomy for Gastric Adenocarcinoma: Should West Meet East?<strong>The oncologist<\/strong>2009;14:871-882.<\/li><\/ul><ul><li>H Derici, I Yaman, T Tansug, O Nazli, et al. Prognostic Factors of Patients With Transmural Advanced Gastric Carcinoma.<strong>Gastroenterology Research<\/strong>2009;2(6):317-323.<\/li><\/ul><ul><li>S Yalcin. Gastric Cancer in Turkey\u2014A Bridge Between West and East.<strong>Gastrointestinal cancer research<\/strong>2009;3(1):29-32.<\/li><\/ul><ul><li>Ozmen MM, Ozmen F, Zulfikaroglu.<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=16&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=1\">Lymph Nodes in Gastric Cancer<\/a><br \/>Journal of Surgical Oncology 2008;98(6):476-481.<\/li><li>Leong CN, Chung HT, Lee KM, et al. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.<strong>Cancer Journal<\/strong>2008;14:269-275.<\/li><\/ul><ul><li>Park JM, Kim JH, Park SS, et al.<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=8&amp;SID=S21INkh8NNPKC2GhJA6&amp;page=1&amp;doc=1\">Prognostic factors and availability of D2 lymph node dissection for the patients with stage II gastric cancer: Comparative analysis of subgroups in stage II<\/a>.<strong>World Journal of Surgery<\/strong>2008;32:1037-1044.<\/li><\/ul><ul><li>Sasagawa T, Solano H, Vega W, Mena F. The effectiveness of extended lymph node dissection for gastric cancer performed in Costa Rica under supervision of a Japanese surgeon: A comparison with surgical results in Japan.<strong>American Journal of Surgery<\/strong>2008;195:53-60.<\/li><\/ul><ul><li>Kim MC, Jung GJ, Kim HH.<a href=\"https:\/\/apps.isiknowledge.com\/WoS\/CIW.cgi?SID=W2L5dJMeOebBBjGDbCn&amp;Func=DispCitingRec&amp;doc=1\/88&amp;isickref=118167848&amp;&amp;pre_set_doc=1\/CIW.cgi?SID=W2L5dJMeOebBBjGDbCn&amp;Func=Abstract&amp;doc=6\/1\">Morbidity and mortality of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer<\/a>.<strong>Digestive Diseases And Sciences<\/strong>2007;52: 543-548.<\/li><\/ul><ul><li>Heidenreich A, Ohlmann CH, Polyakov S. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.<strong>European Urology<\/strong>2007;52: 29-37,<\/li><\/ul><ul><li>Huscher CGS, Mingoli A, Sgarzini G, et al.Totally laparoscopic total and subtotal gastrectomy with extended lymph node dissection for early long-term results and advanced gastric cancer: early and of a 100-patient series.<strong>American Journal of Surgery<\/strong>2007;194: 839-844.<\/li><\/ul><ul><li>Wyler SF, Sulser T, Seifert HH, et al. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.<strong>Urology<\/strong>2006;68:883-887,<\/li><\/ul><ul><li>Burkhard FC, Schumaher M, Thalman GN, Studer UE. Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of &lt; 10 ng\/ml undergoing radical prostatectomy for prostate cancer?<strong>BJU International<\/strong>2005;95(3)275-278.<\/li><\/ul><ul><li>Torres JE, Tsoulfas G, Hamdy K, Scott-Conner CEH. Laparoscopic surgery for the prevention, palliation and cure of gastrointestinal malignancies.<strong>Medical Clinics of North America<\/strong>2005;89(1):187-.<\/li><\/ul><ul><li>Huscher CG, Mingoli A, Sgarzini G, et al. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer.<strong>American Journal of Surgery<\/strong>2004;188(6):728-733.<\/li><\/ul><ul><li>Shimoyama S, Mafune K, Kaminishi M. Indications for a pylorus-preseving gastrectomy for gastric cancer with proper muscle invasion.<strong>Archives of Surgery<\/strong>2003;138:1235-1239.<\/li><\/ul><ul><li>Bostanc\u0131 EB, Yol S, Kayaalp C, \u00d6zo\u011ful Y, Atd\u0131n C, Atalay F, Ako\u011flu M. Comparison of complications after D2 and D3 dissection for gastric cancer.<strong>European Journal of Surgical Oncology<\/strong>2004,30:20-25.<\/li><\/ul><ul><li>Bass BL.What\u2019s new in general surgery: Gastrointestinal conditions.<strong>Journal of the American College of Surgeons<\/strong>2002;195:835-54.<\/li><\/ul><ul><li>Kasakura Y, Mochizuki F, Wakabayashi K, Kochi M, Fujii M, Takayama T. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: A retrospective study of 1403 cases at a single institution.<strong>Journal of Surgical Research<\/strong>2002;103:252-259.<\/li><\/ul><ul><li>Spanknebel KA, Brennan MF. Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention?<strong>Surgical Oncology Clinics Of North America<\/strong>2002;11:415-430.<\/li><\/ul><p><strong>E4<\/strong><strong>\u2013<\/strong>H.Alt\u0131nyollar, U.Berbero\u011flu,<strong>O.\u00c7elen<\/strong>. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip.<strong>European Journal of Surgical Oncology<\/strong>2002;28:72-74.<\/p><ul><li>AR Schmitt, JD Brewer, JS Bordeaux Staging for Cutaneous Squamous Cell Carcinoma as a Predictor of Sentinel Lymph Node Biopsy Results Meta-analysis of American Joint Committee on Cancer Criteria and a Proposed Alternative System<strong>JAMA\u00a0 Dermatol<\/strong>2014;150(1):19-24.<\/li><\/ul><ul><li>Guinot JL, Arribas, L, Vendrell JB et al. Prognostic factors in squamous cell lip carcinoma treated with high-dose-rate brachytherapy<strong>Head &amp; Neck<\/strong>2014;36(12):1737-1742.<\/li><\/ul><ul><li>Allen JE, Stolle LB. Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma<strong>European Journal of Surgical Oncology<\/strong><\/li><\/ul><ul><li>Bassi, KK, Srivastava A, Seenu V et al. The First and Second Echelon Sentinel Lymph Node Evaluation in OraCancer<strong><em>Indian Journal of Surgery<\/em><\/strong>2013;75: 377-382.<\/li><\/ul><ul><li>Vanderlei JPM,<a href=\"https:\/\/scholar.google.com.tr\/citations?user=NoU3ZdUAAAAJ&amp;hl=en&amp;oi=sra\">Pereira-Filho<\/a>FJF , et al. Management of neck metastases in T2N0 lip squamous cell carcinoma.<strong><em>American journal of otolaryngology<\/em><\/strong>2013:34(2): 103-106.<\/li><\/ul><ul><li>Spratt EAG, Carucci JA. Skin Cancer in Immunosuppressed Patients.<strong>Facial Plastic Surgery<\/strong>2013;29: 402-410.<\/li><\/ul><ul><li>Guti\u00e9rrez\u2010Pascual, M., et al. Squamous cell carcinoma of the lip. A retrospective study of 146 patients.<strong>Journal of the European Academy of Dermatology and Venereology<\/strong>2012;16(9):1116-1121.<\/li><\/ul><ul><li>Greenberg JN, Zwald FO. Management of skin cancer in solid-organ transplant recipients: a multidisciplinary approach.<strong>Dermatologic clinics<\/strong>2011;29(2): 231-241.<\/li><\/ul><ul><li>Kwon S, Dong ZM, Wu PC. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature.<strong>World J Surg Oncol<\/strong>2011;9: 80.<\/li><\/ul><ul><li>D Belkin, JA Carucci. Carucci. Mohs surgery for squamous cell carcinoma.<strong>Dermatologic clinics<\/strong>2011;29(2): 161-174.<\/li><\/ul><ul><li>Guibert M, David I, Vergez S et al. Brachytherapy in lip carcinoma: long-term results.<strong>International Journal of Radiation Oncology* Biology* Physics<\/strong>\u00a02011;81(5): e839-e843.<\/li><\/ul><ul><li>Xiqiang L, Kolokythas A, Wang J et al. Gene expression signatures of lymph node metastasis in oral cancer: molecular characteristics and clinical significances.\u00a0<strong>Current cancer therapy reviews<\/strong>\u00a02010;6(4): 294.<\/li><\/ul><ul><li>MA Kuriakose, NP Trivedi. Sentinel node biopsy in head and neck squamous cell carcinoma.\u00a0<strong>Current opinion in otolaryngology &amp; head and neck surgery<\/strong>\u00a02009;17(2): 100-110.<\/li><\/ul><ul><li>Sarper Y, and Ercocen AR. Is Elective Neck Dissection in T1\u20132, N0 Patients With Lower Lip Cancer Necessary?.\u00a0<strong>Annals of plastic surgery<\/strong>\u00a02009;62: 381-383.<\/li><\/ul><ul><li>Civantos F, Zitsch R, Bared A, et al.\u00a0Sentinel node biopsy for squamous cell carcinoma of the head and neck. Journal of Surgical Oncology 2008;97(8):683-690.<\/li><\/ul><ul><li>Reichrath J, Nurnberg.\u00a0Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Sunlight, Vitamin D and Skin Cancer \u00a0Book Series: Advances in Experimental Medicine and Biology 2008;624:203-214.<\/li><\/ul><ul><li>Morselli P, Masciotra L, Pinto V, et al.\u00a0<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=14&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=3\">Clinical parameters in T1NOMO lower lip squamous cell carcinoma<\/a>. Journal of Craniofacial Surgery 2007;18(5):1079-1082.<\/li><\/ul><ul><li>Civantos F, Zitsch R, Bared A.\u00a0<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=14&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=4\">Sentinel node biopsy in oral squamous cell carcinoma<\/a>. Journal of Surgical Oncology2007;96(4)330-336.<\/li><\/ul><ul><li>Renzi C, Caggiati A, Mannooranparampil TJ, et al.\u00a0<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=14&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=5\">Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: Case series and review of the literature<\/a>EJSO 2007;33(3):364-369.<\/li><\/ul><ul><li>Martinez JC, Cook JL.\u00a0<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=14&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=6\">High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: Is there a therapeutic role for elective neck dissection?<\/a>\u00a0Dermatolog\u0131c Surgery 2007;33(4):410-420.<\/li><\/ul><ul><li>Devaney KO, Rinaldo A, Rodrigo JP, et al.\u00a0Sentinel node biopsy and head and neck tumors \u2013 Where do we stand today?Head and Neck-Journal for The Sciences And Specialties of The Head and Neck 2006;28(12):1122-1131.<\/li><\/ul><ul><li>Ross AS, Schmults CD.<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=14&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=8\">Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: A systematic review of the English literature<\/a>. Dermatologic Surgery 2006;32(11):1309-1321.<\/li><\/ul><ul><li>Civantos FJ, Moffat FL, Goodwin WJ.\u00a0Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: Contrasts between oral cavity and cutaneous malignancy\u00a0Laryngoscope \u00a02006;116(3):1-15<\/li><\/ul><ul><li>Cecchi R, Buralli L, De Gaudio C. Lymphatic mapping and sentinel lymphadenectomy in recurrent cutaneous squamous cell carcinomas.\u00a0<strong>European Journal of Dermatology<\/strong>2005;15(6):478-479.<\/li><\/ul><ul><li>Paleri V, Rees G, Arullenoran P, et al. sentinel lymph node biopsy in squamous cell carcinoma in squamous cell cancer of the oral cavity and oral pharynx: A diagnostic meta-analysis.\u00a0<strong>Head and Neck Journal for the Sciences Specialties of the Head and Neck\u00a0<\/strong>2005;27(9):739-747.<\/li><\/ul><ul><li>Somma P, Lo Muzio L, Mansueto G, et al. Squamous cell carcinoma of the lower lip: FAS\/FASL expression, lymphocyte subtypes and outcome.\u00a0<strong>International Journal of Immunopathology and Pharmacology<\/strong>\u00a02005;18(1):59-64.<\/li><\/ul><ul><li>Nouri K, Rivas MP, Pedroso F, et al. Sentinel lymph node biopsy for high risk squamous cell carcinoma of the head and neck.\u00a0<strong>Archives of Dermathology<\/strong>\u00a02004;140(10):1284-1284.<\/li><\/ul><ul><li>Carucci JA. Cutaneous oncology in organ transplant recipients: Meeting the challenge of squamous cell carcinoma.\u00a0<strong>Journal of Investigative Dermatology\u00a0<\/strong>2004;123(5):809-816.<\/li><\/ul><ul><li>Stasko T, Brown MD, Carucci JA, Euvrard S, Johnson TM,Sengelmann RD, Stockfleth E, Tope WD. Guidelines for the management of squamous cell carcinoma in organ transplant recipients.\u00a0<strong>Dermatologic Surgery<\/strong>\u00a02004, 30:642-650.<\/li><\/ul><ul><li>Vartanian JG, Carvalho AL, de Arajo MJ, Hattori M, Magrin J, Kowalski LP. Predictive factors and distribution of lymph node metastasis in lip cancer patients and their implications on the treatment of the neck.\u00a0<strong>Oral Surgery<\/strong>\u00a02004;40:223-227.<\/li><\/ul><ul><li>Carucci JA. Management of squamous cell carcinoma in organ transplant recipients.\u00a0<strong>Seminars in Cutaneous Medicine and Surgery<\/strong>\u00a02003;22:177-186.<\/li><\/ul><ul><li>Blazer DG, Sabel MS, Sondak VK. Is there a role for sentinel lymph node biopsy in the management of sarcoma?\u00a0<strong>Surgical Oncology-Oxford<\/strong>\u00a02003;12:201-206.<\/li><\/ul><ul><li>Pitman KT, Ferlito A, Devaney KO, Shaha AR, Rinaldo A. Sentinel lymph node biopsy in head and neck cancer<strong>. Oral Oncology<\/strong>\u00a02003;39:343-349.<\/li><\/ul><p><strong>E5-<\/strong>\u00a0<strong>O.\u00c7elen<\/strong>, \u0130.Kahraman, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cCorrelation of vascular endothelial growth factor with clinicopathological variables in colorectal cancer patients\u201d,\u00a0<strong>Neoplasma<\/strong>, 2004;51(4), 293-299.<\/p><ul><li>Sun, Y. W., et al. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.\u00a0<strong><em>Genet Mol Res<\/em><\/strong>\u00a02013;12: 1045-53.<\/li><li>Sanchez, B. C., et al. Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF.\u00a0<strong><em>European Journal of Cancer<\/em><\/strong>\u00a02010;46: 1580-1587.<\/li><li>Wang GY, Wang XS, Wang SH, et al.\u00a0<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=11&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=1\">Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues<\/a>. International Journal of Colorectal Disease 2008;23(7):675-682.<\/li><\/ul><ul><li>Li YH, Hu CF, Shao Q, et al.\u00a0Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. Journal Of Translational Medicine \u00a0\u00a02008;6(1).<\/li><\/ul><ul><li>Famulsiki W, Sulkowska M, Wincewics A, et al. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients. Neoplasma 2006;53(1):43-48.<\/li><\/ul><ul><li>Fuckar D, Dekanic A, Stifter S, et al. VEGF expression is associated with negative estrogen receptor status in patient with breast cancer. International Journal of Surgical Pathology 2006; 14(1):49-55.<\/li><\/ul><ul><li>Krishna SM, James S, Balaram P. Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Research 2006; 115(1):85-90.<\/li><\/ul><ul><li>Lin JD, Chao TC. Vascular endothelial growth factor in thyroid cancer. Cancer Biotherapy and Radiopharmaceuticals 2005;20(6):648-661.<\/li><\/ul><p><strong>E6-<\/strong>\u00a0U.Berbero\u011flu, E.Y\u0131ld\u0131r\u0131m,\u00a0<strong>O.\u00c7elen<\/strong>. \u201cSerum levels of tumor necrosis factor alpha correlate with response to neoadjuvant chemotherapy in locally advanced breast cancer\u201d,\u00a0<strong>The International Journal of Biological Markers<\/strong>\u00a02004;19(2):130-134.<\/p><ul><li>Raaschou, Pauline, et al. \u201cTNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study.\u201d\u00a0<strong><em>Annals of the rheumatic diseases<\/em><\/strong>\u00a0(2014): annrheumdis-2014.<\/li><\/ul><ul><li>da Rocha, Aline Franco, et al. Inhibitory effect of tumor necrosis factor \u03b1 on gluconeogenesis in perfused rat liver.\u00a0<strong>Molecular and cellular biochemistry<\/strong>\u00a02013;375: 89-96.<\/li><\/ul><ul><li>Flores-Ramos, L. G\u00f3mez, et al. Association of the tumor necrosis factor-alpha\u2212 308 G&gt; A polymorphism with breast cancer in Mexican women.\u00a0<strong>Genetics and Molecular Research<\/strong>\u00a02013;121(4): 5680-5693.<\/li><\/ul><ul><li>To, Sarah Q., Kevin C. Knower, and Colin D. Clyne. Origins and Actions of Tumor Necrosis Factor \u03b1 in Postmenopausal Breast Cancer.\u00a0<strong>Journal of Interferon &amp; Cytokine Research<\/strong>\u00a02013;33(7): 335-345.<\/li><\/ul><ul><li>Wang X, Lin Y.\u00a0Tumor necrosis factor and cancer, buddies or foes?<br \/>Acta Pharmacologica Sinica \u00a0\u00a02008;29(11):1275-1288.<\/li><\/ul><ul><li>Grim-Stieger M, Keilani M, Mader RM, et al. Serum levels of tumor necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate. Preliminary data of Viennese outpatint with metastatic cancer during palliative chemotherapy. European Journal of Cancer Care 2008;17:454-462.<\/li><\/ul><ul><li>Fagerholm R, Hofstetter B, Tommiska J, et al. NAD(P)H:Quinone oxidoreductase 1 NOO1 (star) 2 genotype (P187S) is astrong prognostic and predictive factor in breast cancer. Nature Genetics 2008;40:844-853.<\/li><\/ul><ul><li>Mills PJ, Ancoli-Israel S, Parker B, et al. Predictors of inflammation in response<\/li><\/ul><p>to anthracycline-based chemotherapy for breast cancer. Brain Behavior and Immunity 2008;22(1):98-104.<\/p><ul><li>Premkumar VG, Yuvaraj S, Vijayasarathy K, et al.Serum cytokine levels of interleukin-1 beta,-6,-8,tumor necrosisfactor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin.\u00a0<strong>Basic and Clinical Pharmacology and Toxicology<\/strong>\u00a02007;100:387-391.<\/li><\/ul><ul><li>Sirotkovic-Skerlev M, Cacev T, Kapitanovic S. Tumor necrosis Factor alpha and breast cancer.\u00a0<strong>Periodicum Biologorum<\/strong>\u00a02006;108:541-546.<\/li><\/ul><ul><li>Beresford M, Padhani AR, Goh V, et al. Imaging breast cancer response during neoadjuvant systemic therapy.\u00a0<strong>Expert review of<\/strong>\u00a0<strong>Anticancer Therapy<\/strong>\u00a02005;5:893-905.<\/li><\/ul><p><strong>E7-<\/strong>\u00a0O.\u00c7elen, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cFactors influencing outcome of surgery for stage I rectal cancer\u201d,\u00a0<strong>Neoplasma<\/strong>\u00a02004;51(6), 487-490 .<\/p><ul><li>Uribarrena A, Rafael, et al. Prognostic value of microvascular density in Dukes A and B (T1\u2013T4, N0, M0) colorectal carcinomas.\u201d\u00a0<strong>Gastroenterology research and practice\u00a0<\/strong>2009 (2009).<\/li><\/ul><ul><li>Uribarrena-Amezaga, R., et al. Prognostic value of lymph node micrometastasis in patients with colorectal cancer in Dukes stages A and B (T1-T4, N0, M0).\u00a0<strong>Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva<\/strong>\u00a02010;102(3): 176-186.<\/li><\/ul><ul><li>Ptok H, Meyer F, Steinert R, et al.\u00a0<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=12&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=1\">No prognostic impact of isolated lymphovascular invasion after radical resection of rectal cancer \u2013 results of a multicenter observational study<\/a>\u00a0International Journal of Colorectal Disease \u00a0\u00a02007;22(7):749-756.<\/li><\/ul><p><strong>E8-\u00a0<\/strong>E. Y\u0131ld\u0131r\u0131m,\u00a0<strong>O. \u00c7elen<\/strong>, K. G\u00fclben and U. Berbero\u011flu. \u201dThe surgical management of incidental gallbladder carcinoma\u201d,\u00a0\u00a0<strong>European Journal of Surgical Oncology\u00a0<\/strong>31(1),45-52 (2005).<\/p><ul><li>Yoon, Jong Hee, et al. \u201cWhat is the Better Choice for T1b Gallbladder Cancer: Simple Versus Extended Cholecystectomy.\u201d\u00a0<em>World journal of surgery<\/em>12 (2014): 3222-3227.<\/li><\/ul><ul><li>Kai, Keita, Shinichi Aishima, and Kohji Miyazaki. \u201cGallbladder cancer: Clinical and pathological approach.\u201d\u00a0<em>World Journal of Clinical Cases: WJCC<\/em>10 (2014): 515.<\/li><\/ul><ul><li>Gryko, M., et al. \u201cCancer of the gallbladder\u2013own experience.\u201d\u00a0<em>Progress in Health Sciences<\/em>1 (2014): 153-157.<\/li><\/ul><ul><li>Salah, Berkane, and Abid Larbi. \u201cEarly Gallbladder Cancer: Clinical, Morphological, Therapeutic and Evolutionary Aspects.\u201d\u00a0<em>Surgical Science<\/em>11 (2013): 486.<\/li><\/ul><ul><li>Behari, Anu, and Vinay K. Kapoor. \u201cIncidental Gall Bladder Cancer.\u201d\u00a0<em>Advances in surgery<\/em>1 (2013): 227-249.<\/li><\/ul><ul><li>Argon, Asuman, et al. \u201cA Different Perspective on Macroscopic Sampling of Cholecystectomy Specimens.\u201d\u00a0<em>Korean journal of pathology<\/em>6 (2013): 519-525.<\/li><\/ul><ul><li>Kumar, Rakesh, et al. \u201cRole of 18F-FDG PET\/CT in detecting recurrent gallbladder carcinoma.\u201d\u00a0<em>Clinical nuclear medicine<\/em>5 (2012): 431-435.<\/li><\/ul><ul><li>Mazer, Laura M., et al. \u201cTumor characteristics and survival analysis of incidental versus suspected gallbladder carcinoma.\u201d\u00a0<em>Journal of Gastrointestinal Surgery<\/em>7 (2012): 1311-1317.<\/li><\/ul><ul><li>Wang, Jing-Han, et al. \u201cEstablishment and characterization of a cell line, EH-GB2, derived from hepatic metastasis of gallbladder cancer.\u201d\u00a0<em>Oncology reports<\/em>3 (2012): 775.<\/li><\/ul><ul><li>Lee, Seung Eun, et al. \u201cSystematic review on the surgical treatment for T1 gallbladder cancer.\u201d\u00a0<em>World journal of gastroenterology: WJG<\/em>2 (2011): 174.<\/li><\/ul><ul><li>T\u00dcZ\u00dcNER, Acar, Esra ERDEN, and Kaan KARAYAL\u00c7IN. \u201cIncidental gallbladder cancer diagnosed during or after laparoscopic cholecystectomy in members of the Turkish population with gallstone disease.\u201d\u00a0<em>Turk J Gastroenterol<\/em>5 (2011): 513-516.<\/li><\/ul><ul><li>Isambert, M., et al. \u201cIncidentally-discovered gallbladder cancer: When, why and which reoperation?.\u201d\u00a0<em>Journal of visceral surgery<\/em>2 (2011): e77-e84.<\/li><\/ul><ul><li>Cho, Seong Yeon, et al. \u201cComparative analysis between clinical outcomes of primary radical resection and second completion radical resection for T2 gallbladder cancer: single-center experience.\u201d\u00a0<em>World journal of surgery<\/em>7 (2010): 1572-1578.<\/li><\/ul><ul><li>He, Xiao-Dong, et al. \u201cGender-specific prognostic markers of patients with gallbladder cancer after surgical resection.\u201d\u00a0<em>The American surgeon<\/em>11 (2010): 1269-1274.<\/li><\/ul><ul><li>Hueman, Matthew T., Charles M. Vollmer Jr, and Timothy M. Pawlik. \u201cEvolving treatment strategies for gallbladder cancer.\u201d\u00a0<em>Annals of surgical oncology<\/em>8 (2009): 2101-2115.<\/li><\/ul><ul><li>Pilgrim, C., Val Usatoff, and Peter M. Evans. \u201cA review of the surgical strategies for the management of gallbladder carcinoma based on T stage and growth type of the tumour.\u201d\u00a0<em>European Journal of Surgical Oncology (EJSO)<\/em>9 (2009): 903-907.<\/li><\/ul><ul><li>Choi, Sae Byeol, et al. \u201cIncidental gallbladder cancer diagnosed following laparoscopic cholecystectomy.\u201d\u00a0<em>World journal of surgery<\/em>12 (2009): 2657-2663.<\/li><\/ul><ul><li>Shibata, Kohei, et al. \u201cLymphatic invasion: an important prognostic factor for stages T1b\u2013T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer.\u201d\u00a0<em>World journal of surgery<\/em>5 (2009): 1035-1041.<\/li><\/ul><ul><li>Reddy, Srinevas K., and Bryan M. Clary. \u201cSurgical management of gallbladder cancer.\u201d\u00a0<em>Surgical oncology clinics of North America<\/em>2 (2009): 307-324.<\/li><\/ul><ul><li>De Aretxabala, Xabier, et al. \u201cEarly gallbladder cancer: is further treatment necessary?.\u201d\u00a0<em>Journal of surgical oncology<\/em>7 (2009): 589-593.<\/li><\/ul><ul><li>Pilgrim, Charles HC, Val Usatoff, and Peter Evans. \u201cConsideration of anatomical structures relevant to the surgical strategy for managing gallbladder carcinoma.\u201d\u00a0<em>European Journal of Surgical Oncology (EJSO)<\/em>11 (2009): 1131-1136.<\/li><\/ul><ul><li>Abramson, Michael A., et al. \u201cRadical resection for T1b gallbladder cancer: a decision analysis.\u201d\u00a0<em>HPB<\/em>8 (2009): 656-663.<\/li><\/ul><ul><li>Yeu, Kyung-jun, et al. \u201cShould the extrahepatic bile duct be resected for T2 gallbladder cancer?.\u201d\u00a0<em>Journal of the Korean Surgical Society<\/em>2 (2009): 113-119.<\/li><\/ul><ul><li>Gourgiotis S, Kocher HM, Solaini L, et al. Gallbladder cancer. American Journal of Surgery 2008;96:252-264.<\/li><\/ul><ul><li>Zulke C, Schlitt HJ. Incidentalomas of the liver and gallbladder \u2013 Evaluation and therapeutic procedure Chirurg \u00a0\u00a02007;78<strong>: 698-712.<\/strong><\/li><\/ul><ul><li>Thomas MB.Biological characteristics of cancers in gallbladder and Biliary tract and targeted therapy.\u00a0<strong>Critical Reviews in Oncology<\/strong>\u00a0<strong>Hematology\u00a0<\/strong>2007;61:44-51.<\/li><\/ul><ul><li>Reid KM, Ramos-De la Medina A, Donohue JH.<a href=\"https:\/\/apps.isiknowledge.com\/WoS\/CIW.cgi?SID=Q2cP2HjFoAnPcD6JpPD&amp;Func=DispCitingRec&amp;doc=1\/40&amp;isickref=142778681&amp;&amp;pre_set_doc=1\/CIW.cgi?SID=Q2cP2HjFoAnPcD6JpPD&amp;Func=Abstract&amp;doc=3\/1\">Diagnosis and surgical management of gallbladder cancer: A review<\/a>.<br \/><strong>Journal of Gastro\u0131ntest\u0131nal Surgery<\/strong>\u00a02007;11: 671-681.<\/li><\/ul><ul><li>Shirai Y, Wakai T, Hatakeyama K.Radical lymph node dissection for gallbladder cancer: Indications and limitations.<strong>Surgical Oncology Clinics of North America<\/strong>2007;16: 221-+.<\/li><\/ul><ul><li>Steinert R, Nestler G, Sagynaliev E, et al. Laparoscopic cholecystectomy and gallbladder cancer.\u00a0<strong>Journal of Surgical\u00a0<\/strong><strong>Oncology\u00a0<\/strong>2006;93:682-689.<\/li><\/ul><ul><li>Misra MC, Gulera S. Management of cancer gallbladder found as a surprise on a resected gallbladder specimen.\u00a0<strong>Journal of Surgical Oncology\u00a0<\/strong>2006;93:690-698.<\/li><\/ul><p><strong>E9-<\/strong>\u00a0<strong>O. \u00c7elen<\/strong>, E Y\u0131ld\u0131r\u0131m, N \u00d6zen, C Sonmez. \u201cPredictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast\u201d carcinoma.\u00a0<strong>Neoplasma\u00a0<\/strong>2006;53,347-51.<\/p><ul><li>Fleitas, T., et al. \u201cVEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.\u201d\u00a0<em>Clinical and Translational Oncology<\/em>11 (2013): 897-902.<\/li><li>Reyn\u00e9s, Gaspar, et al. \u201cCirculating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma.\u201d\u00a0<em>Journal of neuro-oncology<\/em>1 (2011): 35-41.<\/li><\/ul><ul><li>G\u00f6kmen, Selma S., et al. \u201cK\u00fc\u00e7\u00fck H\u00fccreli D\u0131\u015f\u0131 Akci\u011fer Kanserli Hastalarda Sisplatin+ Etoposid Tedavisinin Serum Total ve Lipide Ba\u011fl\u0131 Sialik Asid D\u00fczeylerine Etkisi.\u201d\u00a0<em>T\u00fcrk Biyokimya Dergisi<\/em>3 (2010): 236.<\/li><\/ul><ul><li>Gokmen SS, Kazezoglu C, Tabakoglu E, et al.\u00a0<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=9&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=1\">The importance of serum total and lipid-bound sialic acid as markers in patients with small cell and non-small cell lung carcinoma<\/a>\u00a0Trakya \u00dcn\u0131versitesi T\u0131p Fakultesi Dergisi 2007;24(2):101-108<\/li><\/ul><p><strong>E10-<\/strong>\u00a0<strong>O.\u00c7elen<\/strong>, E.Y\u0131ld\u0131r\u0131m, U.Berbero\u011flu. \u201cPrognost\u0131c impact of positive lymph node ratio in gastric carcinoma\u201d,\u00a0<strong>Journal of Surgical oncology<\/strong>\u00a02007;96(2):95-101 .<\/p><ul><li>Smith, David D., Rebecca A. Nelson, and Roderich E. Schwarz. \u201cA Comparison of Five Competing Lymph Node Staging Schemes in a Cohort of Resectable Gastric Cancer Patients.\u201d\u00a0<em>Annals of surgical oncology<\/em>3 (2014): 875-882.<\/li><\/ul><ul><li>Rosa, Fausto, et al. \u201cLymph node ratio for gastric cancer: useful instrument or just an expedient to retrieve fewer lymph nodes?.\u201d\u00a0<em>Annals of surgery<\/em>4 (2014): e65.<\/li><\/ul><ul><li>Ryu, In Sun, et al. \u201cLymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.\u201d\u00a0<em>Annals of surgical oncology<\/em>1 (2014): 277-283.<\/li><\/ul><ul><li>Aurello, Paolo, et al. \u201cLog Odds of Positive Lymph Nodes (LODDS): What Are Their Role in the Prognostic Assessment of Gastric Adenocarcinoma?.\u201d\u00a0<em>Journal of Gastrointestinal Surgery<\/em>\u00a0(2014): 1-7<\/li><\/ul><ul><li>Zhang, Bao-yan, et al. \u201cEvaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer.\u201d\u00a0<em>The American Journal of Surgery<\/em>4 (2014): 555-565.<\/li><\/ul><ul><li>Lin, Dapeng, et al. \u201cLymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.\u201d\u00a0<em>American journal of clinical oncology<\/em>4 (2013): 325-330.<\/li><\/ul><ul><li>Xu, Jia, et al. \u201cPrognostic assessment of different metastatic lymph node staging methods for gastric cancer after D2 resection.\u201d\u00a0<em>World journal of gastroenterology: WJG<\/em>12 (2013): 1975.<\/li><\/ul><ul><li>Wang, Jiping, et al. \u201cComparison of a lymph node ratio\u2013based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database.\u201d\u00a0<em>Annals of surgery<\/em>3 (2012): 478-485.<\/li><\/ul><ul><li>Lee, Sung Ryol, et al. \u201cPrognostic significance of the metastatic lymph node ratio in patients with gastric cancer.\u201d\u00a0<em>World journal of surgery<\/em>5 (2012): 1096-1101.<\/li><\/ul><ul><li>Lang, Brian Hung-Hin, et al. \u201cSignificance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection.\u201d\u00a0<em>Annals of surgical oncology<\/em>4 (2012): 1257-1263.<\/li><\/ul><ul><li>Deng, Jingyu, et al. \u201cClinicopathologic characteristics and outcomes of surgery of middle-third gastric cancer.\u201d\u00a0<em>Tumor Biology<\/em>6 (2012): 2091-2098.<\/li><\/ul><ul><li>Wang, W., et al. \u201cTumor\u2013ratio\u2013metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection\u2014results of a single-institution study of 1343 Chinese patients.\u201d\u00a0<em>Annals of oncology<\/em>\u00a0(2011): mdq716.<\/li><\/ul><ul><li>Xiao, Long-Bin, et al. \u201cSuperiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer.\u201d\u00a0<em>World journal of gastroenterology: WJG<\/em>46 (2011): 5123.<\/li><\/ul><ul><li>Petrelli, F., K. Borgonovo, and S. Barni. \u201cThe emerging issue of ratio of metastatic to resected lymph nodes in gastrointestinal cancers: an overview of literature.\u201d\u00a0<em>European Journal of Surgical Oncology (EJSO)<\/em>10 (2011): 836-847.<\/li><\/ul><ul><li>Wenguang, Wu, et al. \u201cThree-step method for lymphadenectomy in gastric cancer surgery: a single institution experience of 120 patients.\u201d\u00a0<em>Journal of the American College of Surgeons<\/em>2 (2011): 200-208.<\/li><\/ul><ul><li>Jacomo, Alfredo Luiz, et al. \u201cPrognostic impact of the lymph node metastatic ratio on 5-year survival of patients with rectal cancer not submitted to preoperative chemoradiation.\u201d\u00a0<em>Journal of Coloproctology (Rio de Janeiro)<\/em>4 (2011): 311-324.<\/li><\/ul><ul><li>Sun, Zhe, et al. \u201cLog odds of positive lymph nodes.\u201d\u00a0<em>Cancer<\/em>11 (2010): 2571-2580.<\/li><\/ul><ul><li>Lee, So-Young, et al. \u201cMetastatic lymph node ratio in advanced gastric carcinoma: a better prognostic factor than number of metastatic lymph nodes?.\u201d\u00a0<em>International journal of oncology<\/em>6 (2010): 1461-1467.<\/li><\/ul><ul><li>Maduekwe, Ugwuji N., et al. \u201cNew metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.\u201d\u00a0<em>Annals of surgical oncology<\/em>5 (2010): 1267-1277.<\/li><\/ul><ul><li>Bilici, Ahmet, et al. \u201cDetermining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.\u201d\u00a0<em>Medical Oncology<\/em>3 (2010): 975-984.<\/li><\/ul><ul><li>Pedrazzani, Corrado, et al. \u201cRatio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients.\u201d\u00a0<em>World journal of surgery<\/em>1 (2010): 85-91.<\/li><\/ul><ul><li>Kim, Jin-Soo, et al. \u201cIncreasing nodal ratio is a poor prognostic factor for survival in stage III\u2013IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective study.\u201d\u00a0<em>Japanese journal of clinical oncology<\/em>\u00a0(2010): hyq215.<\/li><\/ul><ul><li>Xu, Da-zhi, et al. \u201cPositive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.\u201d\u00a0<em>Annals of surgical oncology<\/em>2 (2009): 319-326.<\/li><\/ul><ul><li>Sun, Z., et al. \u201cThe impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients.\u201d\u00a0<em>Annals of oncology<\/em>\u00a0(2009): mdn707.<\/li><\/ul><ul><li>Macdonald, O. Kenneth, et al. \u201cPrognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.\u201d\u00a0<em>American journal of clinical oncology<\/em>4 (2009): 411-416.<\/li><\/ul><ul><li>Priolli, D. G., et al. \u201cMetastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients.\u201d\u00a0<em>Techniques in coloproctology<\/em>2 (2009): 113-121.<\/li><\/ul><ul><li>Kim, Chan-Young, and Doo-Hyun Yang. \u201cAdjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes.\u201d\u00a0<em>Annals of surgical oncology<\/em>7 (2009): 1868-1874.<\/li><\/ul><ul><li>Persiani, Roberto, et al. \u201cMetastatic lymph node ratio: a new staging system for gastric cancer.\u201d\u00a0<em>World journal of surgery<\/em>10 (2009): 2106-2111.<\/li><\/ul><ul><li>Wang, Xi, et al. \u201cPrognostic value of the ratio of metastatic lymph nodes in gastric cancer: an analysis based on a Chinese population.\u201d\u00a0<em>Journal of surgical oncology<\/em>6 (2009): 329-334.<\/li><\/ul><ul><li>Hagen, Jeffrey A. \u201cRevisions in the Staging System for Esophageal.\u201d\u00a0<em>Esophageal Cancer: Principles and Practice<\/em>\u00a0(2009): 209.<\/li><\/ul><ul><li>Huang CM, Lin BJ, Lu HS, et al. Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus. World Journal of Surgery 2008;14:4383-4388.<\/li><\/ul><ul><li>Nitti D, Mocellin S, Marchet A, et al.\u00a0<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=2&amp;SID=N2JGLkEj6meNChKei5O&amp;page=1&amp;doc=1\">Recent advances in conventional and molecular prognostic factors for gastric carcinoma<\/a>. Surgical Oncology Clinics of North America \u00a0\u00a02008;17<strong>: 467-+.<\/strong><\/li><\/ul><ul><li>Wang X, Wang JJ, Wan F.\u00a0A common misuse of stepwise regression in studies of ratio of metastatic lymph nodes for gastric cancer.\u00a0<strong>A<\/strong><strong>nnals of Surgical Oncology<\/strong>\u00a0\u00a0\u00a02008;15: 1805-1806.<\/li><\/ul><ul><li>Zheng HC, Tsuneyama K, Takahashi H, et al. Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.\u00a0<strong>Journal of Cancer Research and Clinical Oncology<\/strong>\u00a02008;134<strong>: 481-488.<\/strong><\/li><\/ul><p><strong>E11-<\/strong>\u00a0K. G\u00fclben, U. Berbero\u011flu,\u00a0<strong>O. \u00c7elen<\/strong>, H.H.Mersin. \u201cIncidental papillary microcarcinoma of the thyroid-factors affecting lymph node metastasis\u201d,\u00a0<strong>Langenbecks Archives of Surger<\/strong>y 2008;333(1):25-29.<\/p><ul><li>Mehanna, Hisham, et al. \u201cDifferences in the Recurrence and Mortality Outcomes Rates of Incidental and Nonincidental Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis of 21 329 Person-Years of Follow-Up.\u201d\u00a0<em>The Journal of Clinical Endocrinology &amp; Metabolism<\/em>\u00a0(2014).<\/li><\/ul><ul><li>Brito, Juan P., Ian D. Hay, and John C. Morris. \u201cLow risk papillary thyroid cancer.\u201d\u00a0<em>BMJ<\/em>\u00a0348 (2014).<\/li><\/ul><ul><li>Girardi, F\u00e1bio Murad\u00e1s, Marinez Bizarro Barra, and Cl\u00e1udio Galleano Zettler. \u201cPredictive Factors for Lymph Node Metastasis in Solitary Papillary Thyroid Carcinomas: A Retrospective Study.\u201d\u00a0<em>Pathology &amp; Oncology Research<\/em>\u00a0(2014): 1-6.<\/li><\/ul><ul><li>Vinagre, Jo\u00e3o, et al. \u201cDifferentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature.\u201d\u00a0<em>Molecular Diagnostics<\/em>\u00a01 (2014): 10.<\/li><\/ul><ul><li>Nakamura, Masanori, et al. \u201cE\u2011cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma.\u201d\u00a0<em>Molecular and clinical oncology<\/em>2 (2014): 226-232.<\/li><\/ul><ul><li>Varshney, R., et al. \u201cLymph node metastasis in thyroid papillary microcarcinoma: a study of 170 patients.\u201d\u00a0<em>The Journal of Laryngology &amp; Otology<\/em>10 (2014): 922-925.<\/li><\/ul><ul><li>Yang, Yinlong, et al. \u201cPrediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma.\u201d\u00a0<em>Clinical endocrinology<\/em>\u00a0(2014).<\/li><\/ul><ul><li>Ardito, Guglielmo, et al. \u201cAggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.\u201d\u00a0<em>Clinical nuclear medicine<\/em>1 (2013): 25-28.<\/li><\/ul><ul><li>Zhao, Qunzi, et al. \u201cMultifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.\u201d\u00a0<em>Annals of surgical oncology<\/em>3 (2013): 746-752.<\/li><\/ul><ul><li>Konturek, Aleksander, et al. \u201cPrognostic factors in differentiated thyroid cancer\u2014a 20-year surgical outcome study.\u201d\u00a0<em>Langenbeck\u2019s Archives of Surgery<\/em>5 (2012): 809-815.<\/li><\/ul><ul><li>Jee, Ye Seob. \u201cFirst experiences with laparoscopic assisted distal gastrectomy: in the view of comparison with high volume centers.\u201d\u00a0<em>Journal of the Korean Surgical Society<\/em>3 (2012): 130-134.<\/li><\/ul><ul><li>Tanriover, Ozlem, et al. \u201cOccult papillary thyroid carcinoma: prevalence at autopsy in Turkish people.\u201d\u00a0<em>European Journal of Cancer Prevention<\/em>4 (2011): 308-312.<\/li><\/ul><ul><li>Kamer, Erdin\u00e7, et al. \u201cTiroidin rastlant\u0131sal papiller mikrokarsinomlar\u0131.\u201d\u00a0<em>Journal of Dialog in Endocrinology\/Endokrinolide Diyalog Dergisi<\/em>3 (2011).<\/li><\/ul><ul><li>Sakorafas, George H., Dimitrios Sampanis, and Michael Safioleas. \u201cCervical lymph node dissection in papillary thyroid cancer: current trends, persisting controversies, and unclarified uncertainties.\u201d\u00a0<em>Surgical oncology<\/em>2 (2010): e57-e70.<\/li><\/ul><ul><li>Zafon, Carles, et al. \u201cDifferences in the form of presentation between papillary microcarcinomas and papillary carcinomas of larger size.\u201d\u00a0<em>Journal of thyroid research<\/em>\u00a02011 (2010).<\/li><\/ul><ul><li>Gelmini, Roberta, et al. \u201cIncidental thyroid carcinoma (ITC): a retrospective study in a series of 737 patients treated for benign disease.\u201d\u00a0<em>Ann Ital Chir<\/em>6 (2010): 421-7.<\/li><\/ul><ul><li>Lee, Nam Seop, et al. \u201cRisk factors of lymph node metastasis in papillary thyroid microcarcinoma.\u201d\u00a0<em>Journal of the Korean Surgical Society<\/em>2 (2010): 82-86.<\/li><\/ul><ul><li>Kim, Ju-Yeon, et al. \u201cClinical characteristics and prognosis of multifocal papillary thyroid carcinoma.\u201d\u00a0<em>Journal of the Korean Surgical Society<\/em>6 (2010): 442-446.<\/li><\/ul><ul><li>Mercante, Giuseppe, et al. \u201cPrognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.\u201d\u00a0<em>Thyroid<\/em>7 (2009): 707-716.<\/li><\/ul><ul><li>Chung, Yoo Seung, et al. \u201cLateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.\u201d\u00a0<em>Thyroid<\/em>3 (2009): 241-246.<\/li><\/ul><ul><li>G\u00fcl, Kamile, et al. \u201cComparison of Papillary Thyroid Microcarcinoma and Carcinoma.\u201d\u00a0<em>Turkish Journal of Endocrinology &amp; Metabolism<\/em>3 (2009).<\/li><\/ul><ul><li>Pakdaman MN, Rochon L, Gologan O, et al.Incidence and histopathological behavior of papillary microcarcinomas: Study of 429 cases. Otolaryngology-Head and Neck Surgery \u00a0\u00a02008;139:718-722.<\/li><\/ul><ul><li>Roh JL, Kim JM, Park.\u00a0<a href=\"https:\/\/apps.isiknowledge.com\/full_record.do?product=UA&amp;colname=WOS&amp;search_mode=CitingArticles&amp;qid=7&amp;SID=R1E8md3dLp5DmIj9bh3&amp;page=1&amp;doc=2\">Central cervical nodal metastasis from papillary thyroid microcarcinoma: Pattern and factors predictive of nodal metastasis<\/a>. Annals of Surgical Oncology \u00a0\u00a02008;15:2482-<strong>2<\/strong><\/li><\/ul><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div id=\"div_block-5-88\" class=\"ct-div-block\"><div id=\"div_block-317-347\" class=\"ct-div-block sidebar-mavi-div\"><div id=\"fancy_icon-319-347\" class=\"ct-fancy-icon\">\u00a0<\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-0d7d8da\" data-id=\"0d7d8da\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-013b5a4 elementor-widget elementor-widget-sidebar\" data-id=\"013b5a4\" data-element_type=\"widget\" data-widget_type=\"sidebar.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"widget_text chw-widget\"><div class=\"textwidget custom-html-widget\">\t\t<div data-elementor-type=\"section\" data-elementor-id=\"17719\" class=\"elementor elementor-17719\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>\u0421\u043f\u0435\u0446\u0438\u0430\u043b\u0438\u0441\u0442 \u043f\u043e \u043e\u0431\u0449\u0435\u0439 \u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438 \u0438 \u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438<\/p>\n","protected":false},"author":3,"featured_media":3235,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[241],"tags":[],"class_list":["post-4986","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-241"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d - Neolife T\u0131p Merkezi<\/title>\n<meta name=\"robots\" content=\"index, nofollow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/\" \/>\n<meta name=\"twitter:label1\" content=\"\u041d\u0430\u043f\u0438\u0441\u0430\u043d\u043e \u0430\u0432\u0442\u043e\u0440\u043e\u043c\" \/>\n\t<meta name=\"twitter:data1\" content=\"irm\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u041f\u0440\u0438\u043c\u0435\u0440\u043d\u043e\u0435 \u0432\u0440\u0435\u043c\u044f \u0434\u043b\u044f \u0447\u0442\u0435\u043d\u0438\u044f\" \/>\n\t<meta name=\"twitter:data2\" content=\"53 \u043c\u0438\u043d\u0443\u0442\u044b\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/\"},\"author\":{\"name\":\"irm\",\"@id\":\"https:\/\/www.neolife.com.tr\/#\/schema\/person\/93c281f5da320670a05fe2e5179df604\"},\"headline\":\"\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d\",\"datePublished\":\"2021-07-25T15:24:04+00:00\",\"dateModified\":\"2023-04-26T13:55:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/\"},\"wordCount\":9216,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.neolife.com.tr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/07\/orhan-celen-genel-cerrahi-cerrahi-onkoloji-uzmani-neolife-kanser-merkezi2.jpg\",\"articleSection\":[\"\u0434\u043e\u043a\u0442\u043e\u0440\"],\"inLanguage\":\"ru-RU\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/\",\"url\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/\",\"name\":\"\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d - Neolife T\u0131p Merkezi\",\"isPartOf\":{\"@id\":\"https:\/\/www.neolife.com.tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/07\/orhan-celen-genel-cerrahi-cerrahi-onkoloji-uzmani-neolife-kanser-merkezi2.jpg\",\"datePublished\":\"2021-07-25T15:24:04+00:00\",\"dateModified\":\"2023-04-26T13:55:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#breadcrumb\"},\"inLanguage\":\"ru-RU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#primaryimage\",\"url\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/07\/orhan-celen-genel-cerrahi-cerrahi-onkoloji-uzmani-neolife-kanser-merkezi2.jpg\",\"contentUrl\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/07\/orhan-celen-genel-cerrahi-cerrahi-onkoloji-uzmani-neolife-kanser-merkezi2.jpg\",\"width\":200,\"height\":245},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Ana Sayfa\",\"item\":\"https:\/\/www.neolife.com.tr\/ru\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u0434\u043e\u043a\u0442\u043e\u0440\",\"item\":\"https:\/\/www.neolife.com.tr\/ru\/kategori\/%d0%b4%d0%be%d0%ba%d1%82%d0%be%d1%80\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neolife.com.tr\/#website\",\"url\":\"https:\/\/www.neolife.com.tr\/\",\"name\":\"Neolife T\u0131p Merkezi\",\"description\":\"T\u00fcrkiye&#039;de kanser tedavisi - kanser te\u015fhisi ve tedavisi\",\"publisher\":{\"@id\":\"https:\/\/www.neolife.com.tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neolife.com.tr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ru-RU\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.neolife.com.tr\/#organization\",\"name\":\"Neolife T\u0131p Merkezi\",\"url\":\"https:\/\/www.neolife.com.tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\/\/www.neolife.com.tr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/06\/Neolife-Logo.png\",\"contentUrl\":\"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/06\/Neolife-Logo.png\",\"width\":348,\"height\":92,\"caption\":\"Neolife T\u0131p Merkezi\"},\"image\":{\"@id\":\"https:\/\/www.neolife.com.tr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/NeoLifeIstanbul\/\",\"https:\/\/x.com\/NeoLifeIstanbul\",\"https:\/\/www.linkedin.com\/company\/neolife-oncology-center\/?originalSubdomain=tr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.neolife.com.tr\/#\/schema\/person\/93c281f5da320670a05fe2e5179df604\",\"name\":\"irm\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d - Neolife T\u0131p Merkezi","robots":{"index":"index","follow":"nofollow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/","twitter_misc":{"\u041d\u0430\u043f\u0438\u0441\u0430\u043d\u043e \u0430\u0432\u0442\u043e\u0440\u043e\u043c":"irm","\u041f\u0440\u0438\u043c\u0435\u0440\u043d\u043e\u0435 \u0432\u0440\u0435\u043c\u044f \u0434\u043b\u044f \u0447\u0442\u0435\u043d\u0438\u044f":"53 \u043c\u0438\u043d\u0443\u0442\u044b"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#article","isPartOf":{"@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/"},"author":{"name":"irm","@id":"https:\/\/www.neolife.com.tr\/#\/schema\/person\/93c281f5da320670a05fe2e5179df604"},"headline":"\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d","datePublished":"2021-07-25T15:24:04+00:00","dateModified":"2023-04-26T13:55:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/"},"wordCount":9216,"commentCount":0,"publisher":{"@id":"https:\/\/www.neolife.com.tr\/#organization"},"image":{"@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/07\/orhan-celen-genel-cerrahi-cerrahi-onkoloji-uzmani-neolife-kanser-merkezi2.jpg","articleSection":["\u0434\u043e\u043a\u0442\u043e\u0440"],"inLanguage":"ru-RU","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/","url":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/","name":"\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d - Neolife T\u0131p Merkezi","isPartOf":{"@id":"https:\/\/www.neolife.com.tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#primaryimage"},"image":{"@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/07\/orhan-celen-genel-cerrahi-cerrahi-onkoloji-uzmani-neolife-kanser-merkezi2.jpg","datePublished":"2021-07-25T15:24:04+00:00","dateModified":"2023-04-26T13:55:20+00:00","breadcrumb":{"@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#breadcrumb"},"inLanguage":"ru-RU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/"]}]},{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#primaryimage","url":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/07\/orhan-celen-genel-cerrahi-cerrahi-onkoloji-uzmani-neolife-kanser-merkezi2.jpg","contentUrl":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/07\/orhan-celen-genel-cerrahi-cerrahi-onkoloji-uzmani-neolife-kanser-merkezi2.jpg","width":200,"height":245},{"@type":"BreadcrumbList","@id":"https:\/\/www.neolife.com.tr\/ru\/doc-dr-orhan-celen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ana Sayfa","item":"https:\/\/www.neolife.com.tr\/ru\/"},{"@type":"ListItem","position":2,"name":"\u0434\u043e\u043a\u0442\u043e\u0440","item":"https:\/\/www.neolife.com.tr\/ru\/kategori\/%d0%b4%d0%be%d0%ba%d1%82%d0%be%d1%80\/"},{"@type":"ListItem","position":3,"name":"\u0414\u043e\u0446\u0435\u043d\u0442, \u0414\u043e\u043a\u0442\u043e\u0440 \u041e\u0440\u0445\u0430\u043d \u0427\u0415\u041b\u0415\u041d"}]},{"@type":"WebSite","@id":"https:\/\/www.neolife.com.tr\/#website","url":"https:\/\/www.neolife.com.tr\/","name":"Neolife T\u0131p Merkezi","description":"T\u00fcrkiye&#039;de kanser tedavisi - kanser te\u015fhisi ve tedavisi","publisher":{"@id":"https:\/\/www.neolife.com.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neolife.com.tr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ru-RU"},{"@type":"Organization","@id":"https:\/\/www.neolife.com.tr\/#organization","name":"Neolife T\u0131p Merkezi","url":"https:\/\/www.neolife.com.tr\/","logo":{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/www.neolife.com.tr\/#\/schema\/logo\/image\/","url":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/06\/Neolife-Logo.png","contentUrl":"https:\/\/www.neolife.com.tr\/wp-content\/uploads\/2021\/06\/Neolife-Logo.png","width":348,"height":92,"caption":"Neolife T\u0131p Merkezi"},"image":{"@id":"https:\/\/www.neolife.com.tr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/NeoLifeIstanbul\/","https:\/\/x.com\/NeoLifeIstanbul","https:\/\/www.linkedin.com\/company\/neolife-oncology-center\/?originalSubdomain=tr"]},{"@type":"Person","@id":"https:\/\/www.neolife.com.tr\/#\/schema\/person\/93c281f5da320670a05fe2e5179df604","name":"irm"}]}},"_links":{"self":[{"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/posts\/4986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/comments?post=4986"}],"version-history":[{"count":4,"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/posts\/4986\/revisions"}],"predecessor-version":[{"id":16651,"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/posts\/4986\/revisions\/16651"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/media\/3235"}],"wp:attachment":[{"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/media?parent=4986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/categories?post=4986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.neolife.com.tr\/ru\/wp-json\/wp\/v2\/tags?post=4986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}